CURRICULUM VITAE

CURRICULUM VITAE
NAME:
DANIEL M. GREEN
OFFICE ADDRESS:
Department of Epidemiology & Cancer Control
St. Jude Children's Research Hospital
262 Danny Thomas Place
Mail Stop 735
Memphis, Tennessee 38105-3678
Telephone: (901) 595-5915
ACADEMIC DEGREES:
B.S.
M.D.
1969
1973
Massachusetts Institute of Technology, Cambridge, MA
Cum Laude, St. Louis University School of Medicine, St. Louis, MO
PROFESSIONAL APPOINTMENTS:
Internships/Residencies/Post-Doctoral Fellowships
1973-1974
1974-1975
1975-1978
1975-1978
1975-1978
Intern, Pediatrics, Boston City Hospital, Boston, Massachusetts
Resident, Pediatrics, Boston City Hospital, Boston, Massachusetts
Fellow, Pediatric Oncology, Sidney Farber Cancer Institute, Boston,
Massachusetts
Fellow, Medicine, Hematology-Oncology, Children's Hospital Medical Center,
Boston, Massachusetts
Research Fellow, Pediatrics, Harvard Medical School, Boston, Massachusetts
Appointments
1978-1982
1982-1983
1978-1985
1985-1986
1986-1989
1978-1990
1983-1990
1990-1993
1990-1993
1990-1993
1993-1999
1990-2008
Research Assistant Professor of Pediatrics, School of Medicine and Biomedical
Sciences, University at Buffalo, State University of New York, Buffalo, New York
Assistant Professor of Pediatrics, School of Medicine and Biomedical Sciences,
University at Buffalo, State University of New York, Buffalo, New York
Special Consultant in Hematology-Oncology, The Children's Hospital of Buffalo,
Buffalo, New York
Assistant Attending, The Children's Hospital of Buffalo, Buffalo, New York
Associate Attending, The Children's Hospital of Buffalo, Buffalo, New York
Cancer Research Pediatrician II, Roswell Park Memorial Institute, Buffalo, New
York
Associate Professor of Pediatrics, School of Medicine and Biomedical Sciences,
University at Buffalo, State University of New York, Buffalo, New York
Section Chief, Section of Pediatric Oncology, Department of Pediatrics, Roswell
Park Memorial Institute, Buffalo, New York
Section Director, Section of Oncology, Division of Hematology-Oncology,
Department of Pediatrics, The Children's Hospital of Buffalo, Buffalo, New York
Section Director, Section of Oncology, Division of Hematology-Oncology,
Department of Pediatrics, School of Medicine and Biomedical Sciences,
University at Buffalo, State University of New York, Buffalo, New York
Associate Chief, Department of Pediatrics, Roswell Park Cancer Institute,
Buffalo, New York
Professor of Pediatrics, School of Medicine and Biomedical Sciences, University
at Buffalo, State University of New York, Buffalo, New York
GREEN - 2
1989-2008
1999-2008
2006-2008
2008-present
2008-present
2008-2011
Attending, The Children's Hospital of Buffalo, Buffalo, New York
Staff Physician, Department of Pediatrics, Roswell Park Cancer Institute, Buffalo,
New York
Professor of Oncology, Roswell Park Cancer Institute, Buffalo, New York
Member, Department of Epidemiology and Cancer Control, St. Jude Children’s
Research Hospital, Memphis, Tennessee
Member, Division of Cancer Survivorship, Department of Oncology, St. Jude
Children’s Research Hospital, Memphis, Tennessee
Adjunct Professor of Medicine, Division of General Internal Medicine and Public
Health, Department of Medicine, Vanderbilt School of Medicine, Nashville,
Tennessee
PROFESSIONAL SOCIETY MEMBERSHIPS:
19781993
1998
1999
2001
1979198019801989-92
1992-95
1999-03
2003-06
19811995
19811982
1992-94
1994
1981198319901990
19922012
American Society of Clinical Oncology
Chairman, Program Committee, Pediatric Solid Tumors
Chemo/Radio Protectants Expert Panel
Health Services Research Committee
Program Committee, Pediatric Oncology
American Association for Cancer Research
American Federation for Clinical Research
International Society of Pediatric Oncology
Scientific Committee
Scientific Committee
Secretary-General
Secretary-General
American Society of Pediatric Hematology-Oncology
Membership Committee
American Academy of Pediatrics
Oncology-Hematology Section
Executive Committee
Secretary/Treasurer
American Society of Hematology
New York Academy of Sciences
Society for Pediatric Research
European Society for Pediatric Research, Affiliate Member
American Pediatric Society
American Pediatric Surgical Association (honorary lifetime membership)
HONORS AND AWARDS:
1972
1973
1984
1992
2009201020091994
1996
200220052012
Alpha Omega Alpha
Francis D. Grogan Award in Psychiatry
Who's Who in Frontier Science and Technology, 1st Edition
st
Who’s Who in Science and Engineering, 1 Edition
Who’s Who in America
Who’s Who in the South and Southwest
Who's Who in Medicine and Healthcare
The Best Doctors in America
The Best Doctors in America, Northeast Region
America’s Top Doctors
America’s Top Doctors for Cancer
Robert E. Gross Memorial Lecture – American Pediatric Surgical Association
CERTIFICATION/LICENSURE:
1974-93
Massachusetts; #37337
GREEN - 3
1978-2009
1991-93
2007-present
New York; #135776
California; #G-071426
Tennessee; #42775
1974
1978
1983-86
1978
1986
1997
National Board of Medical Examiners (No. 136831)
American Board of Pediatrics (No. R83-021391)
Re-Certification for Pediatrics
Sub-Board of Pediatric Hematology-Oncology (No. SR86-344)
Recertification of Pediatric Hematology-Oncology
Recertification in Pediatric Subspecialties (PRCP-S); Hematology-Oncology
RESEARCH INTERESTS:
GRANT SUPPORT:
Active
Gabrielle's Angel FDN Vibration Intervention for Bone Enhancement in Childhood Cancer Survivors, Coinvestigator, (12/09-12/12)
NIH/NCI, 1R01CA157838-01A1, Longitudinal Cardiotoxicity in Adult Survivors of Childhood Cancer, Coinvestigator, (02/12-12/16).
NCI, 5U24CA55727, Childhood Cancer Survivor Study, Co-Investigator, (12/11-11/16).
NCI, CA54498, Late Effects of Wilms' Tumor Survivors and Offspring, Co-Investigator, (12/11-11/16).
Inactive
NCI, 5R13CA95124, Conference on Long-term Complications of Children/Adolescents & Cancer,
Principal Investigator, (06/02-5/13).
NICHD, HD061296, Predictors of Adolescent Sperm Banking: Development of a Profiling and Referral
Tool, Co-investigator (07/10-06/12)
Roswell Park Alliance Long-Term Follow-Up Program, Principal Investigator, (06/00-07/04).
NCI, CA42326, National Wilms’ Tumor Study Group, Principal Investigator, (06/91-12/03).
NCI, CA77561, Conference on the Complications of Treatment, Principal Investigator, (04/98-03/99).
NCI, CA78933, Biological Prognostic Factors in Wilms’ Tumor, Principal Investigator, (08/98-07/99).
Roswell Park Alliance, Investigation of Survivors of Childhood Cancer, Principal Investigator, (12/9711/99).
AROCC, Fatigue in Survivors of Hodgkin Disease, Principal Investigator, (12/97-11/99).
NCI, CA71407, Conference of the Complications of Treatment, Principal Investigator, (07/96-06/97).
NCI, CA60114, Biologic Prognostic Factors in Wilms’ Tumor Patients, Principal Investigator, (07/9306/96).
NCI, CA46784, Late Effects of Wilms’ Tumor Survivors and Offspring, Consultant, (04/91-03/96).
GREEN - 4
NCI, CA56458, Conference on the Complication of Treatment, Principal Investigator, (04/92-03/93).
AROCC, Long Term Survivors of Childhood Cancer, Principal Investigator, (06.87-06/92).
AROCC, Identification of the 11p13 Wilms’ Tumor Gene, Co-Investigator, (03/90-02/92).
NCI, CA51048, Conference on Complications of Treatment of Children and Adolescents with Cancer,
Principal Investigator, (02/90-01/91).
Buffalo Bills Foundation, Principal Investigator, (10/88-09/90).
AROCC, Cytogenetic Analysis of Cells Derived From Childhood Tumors, Co-Investigator, (07/85-06/86).
ACS, Prevention of Chronic Hepatic, Pulmonary and CNS Toxicity Due to MTX/6-MP with Coline,
Principal Investigator, (09/80-09/81).
Dorothea Haus Ross, Late Effects of Treatment of Childhood Cancer on the Patient and His/Her Progeny,
Principal Investigator, (06/84-09/81).
N01-CP-91049, Late Effects Study Group, Principal Investigator, (07/79-06/81).
PUBLICATIONS:
1.
Original Articles
Buchanan GR, Green DM, Handin RI. Combined von Willebrand's disease and Hageman factor
deficiency. J Pediatr 90:779-781, 1977.
2.
Green DM, Sallan SE, Krishan A. Actinomycin D in childhood acute lymphocytic leukemia.
Cancer Treat Rep 62:829-831, 1978.
3.
Dritschillo A, Weichselbaum R, Cassady JR, Jaffe N, Green DM, Filler RM. The role of radiation
therapy in the treatment of soft tissue sarcomas of childhood. Cancer 42:1192-1203, 1978.
4.
Green DM, Jaffe N. Progress and controversy in the treatment of childhood rhabdomyosarcoma.
Cancer Treat Rev 5:7-27, 1978.
5.
Green DM, Jaffe N. Wilms' tumor - The model of a curable pediatric malignant solid tumor.
Cancer Treat Rev 5:143-172, 1978.
6.
Green DM. Evaluation of single dose vincristine, actinomycin D and cyclophosphamide in
childhood solid tumors. Cancer Treat Rep 62:1517-1520, 1978.
7.
Green DM, Jaffe N. The role of chemotherapy in the treatment of Wilms' tumor. Cancer 44:52-57,
1979.
8.
Green DM, Stutzman LE, Blumenson LE, Brecher ML, Thomas PRM, Allen JE, Jewett TC,
Freeman AI. The incidence of post-splenectomy sepsis and herpes zoster in children and
adolescents with Hodgkin's disease. Med Pediatr Oncol 7:285-297, 1979.
9.
Green DM, Sather HN, Sallan SE, Nesbit ME Jr, Freeman AI, Cassady JR, Sinks LF, Hammond
D, Frei E III. A comparison of three methods of central nervous system prophylaxis in childhood
acute lymphoblastic leukemia. Lancet 1:1398-1402, 1980.
GREEN - 5
10.
Green DM, Brecher ML, Yakar D, Blumenson LE, Lindsay AN, Voorhess ML, MacGillivray MH,
Freeman AI. Thyroid function in pediatric patients after neck irradiation for Hodgkin's disease.
Med Pediatr Oncol 8:127-136, 1980.
11.
Green DM, Brecher ML, Lindsay AL, Yakar D, Voorhess ML, MacGillivray M, Freeman AI.
Gonadal function in pediatric patients following treatment for Hodgkin's disease. Med Pediatr
Oncol 9:235-244, 1981.
12.
Williams PD, Green DM, Murphy GP. Evaluation of triple drug chemotherapy with or without
right nephrectomy in the treatment of bilateral murine Wilms' tumor. Res Comm Chem Pathol
Pharmacol 34:333-344, 1981.
13.
Green DM, Fine WE, Li FP. Offspring of patients treated for unilateral Wilms' tumor in childhood.
Cancer 49:2285-2288,1982.
14.
Green DM, West CR, Brecher ML, Ettinger LJ, Bakshi S, Berger P, Parthasarathy KL, Freeman
AI. The use of subcutaneous cerebrospinal fluid reservoirs for the prevention and treatment of
meningeal relapse of acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 4:147-154,
1982.
15.
Green DM. Fever and bacteremia in children and adolescents with acute lymphoblastic leukemia.
Am J Pediatr Hematol Oncol 4:263-271,1982.
16.
Green DM. Second malignancy in acute lymphocytic leukemia. Am J Dis Child 136:175
(Letter),1982.
17.
Green DM, Brecher ML, Blumenson LE, Grossi M, Freeman AI. The use of intermediate dose
methotrexate in increased risk childhood acute lymphoblastic leukemia: A comparison of three
versus six courses. Cancer 50:2722-2727, 1982.
18.
Green DM, Yakar D, Brecher ML, Lindsay AN, Voorhess ML, MacGillivray MH. Ovarian function
in adolescent women following successful treatment for non-Hodgkin's lymphoma. Am J Pediatr
Hematol Oncol 5:27-31, 1983.
19.
Wu YF, Green DM, Duffner PK, Dwoskin J, Brecher ML, Piver MS, Panahon A, Cooney DR.
Incontinence of urine and stool following pelvic irradiation in infancy for embryonal
rhabdomyosarcoma. Oncology 40:90-94, 1983.
20.
Green DM, Brecher ML, Grossi M, Simpson L, Fisher J, Allen JE, Cooney DR, Jewett TC,
Freeman AI. The use of different induction and maintenance chemotherapy regimens for the
treatment of advanced yolk sac tumors. J Clin Oncol 1:111-116,1983.
21.
Green DM, Ghoorah J, Douglass HO Jr, Allen JE, Berjian RJ, Jewett TC, Brecher ML, Henderson
ES, Freeman AI. Staging laparotomy with splenectomy in children and adolescents with
Hodgkin's disease. Cancer Treat Rev 10:23-38, 1983.
22.
Green DM, Williams PD, Simpson L, Blumenson LE, Murphy GP. Evaluation of the chronic
hepatic toxicity of 6-mercaptopurine in the Wistar rat. Oncology 40:138-142, 1983.
23.
Salvi S, Green DM, Brecher ML, Magoss I, Gamboa LN, Fisher JE, Baliah T, Afshani E. Renal
artery stenosis and hypertension following abdominal irradiation for Hodgkin's disease:
Successful treatment with nephrectomy. Urology 11:611-615, 1983.
24.
Grossi M, Green DM. Staphylococcus aureus bacteremia in children and adolescents with acute
lymphoblastic leukemia. Oncology 40:321-325, 1983.
GREEN - 6
25.
Green DM. The diagnosis and treatment of yolk sac tumor in infants and children. Cancer Treat
Rev 10:265-288, 1983.
26.
Li FP, Yan JC, Sallan S, Cassady JR, Danahy J, Fine W, Gelber RD, Green DM. Second
neoplasms after Wilms' tumor in childhood. J Natl Cancer Inst 71:1205-1209, 1983.
27.
Green DM, Blumenson LE, Brecher ML, Grossi M, Freeman AI. The effect of pneumococcal
vaccine and prophylactic antibiotics on the rate of pneumococcal bacteremia in splenectomized
pediatric patients with Hodgkin's disease. Eur Paediatr Haematol Oncol 1:225-229, 1984.
28.
Sufrin G, Green DM, Pontes JE, Williams P, Murphy GP. The effect of unilateral nephrectomy on
growth of the Wistar/Furth Wilms' tumor. J Urol 131:378-382, 1984.
29.
Green DM, Williams P, Murphy GP. Evaluation of combination chemotherapy in Wistar/Furth rats
bearing transplantable Wilms' tumor. Oncology 41:39-42, 1984.
30.
Green DM, Williams PD, Murphy GP. The treatment of murine Wilms' tumor with chemotherapy
after intramuscular tumor inoculation and amputation. Oncology 41:185-188, 1984.
31.
Bader JL, Li FP, Olmstead M, Strickman NA, Green DM. Childhood malignant melanoma:
Incidence and etiology. Am J Pediatr Hematol Oncol 17:341-345, 1985.
32.
Green DM. The diagnosis and management of Wilms' tumor. Pediatr Clin NA 32:735-754, 1985.
33.
Brecher ML, Gardner RV, Ettinger LJ, Tebbi CK, Green DM, Freeman AI. High dose
cyclophosphamide (HDC) and intermediate dose methotrexate (IDM) for the treatment of faradvanced Burkitt's lymphoma. Am J Pediatr Hematol Oncol 7:117-124, 1985.
34.
Meadows AT, Baum E, Fossati-Bellani F, Green D, Jenkin RDT, Marsden B, Nesbit M, Newton
W, Oberlin O, Sallan S, Siegel S, Strong LC, Voute PA. Second malignant neoplasms in children:
An update from the Late Effects Study Group. J Clin Oncol 3:532-538, 1985.
35.
Green DM, Marinello MJ, Fisher J, Mindell ER, Zak TA, Allen JE, Khan AR, Brecher ML. Ewing's
sarcoma of the scapula with metastases to the lung and eye. Am J Pediatr Hematol Oncol 8:134143, 1986.
36.
Green DM. Testicular tumors in infants and children. Sem Surg Oncol 2:156-162, 1986.
37.
Green DM. Childhood cancer in siblings. Pediatr Hematol Oncol 3:229-239, 1986.
38.
Green DM, Gingell R, Pearce J, Panahon A, Ghoorah J. The effect of mediastinal irradiation on
cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. J
Clin Oncol 5:239-245, 1987.
39.
Green DM. The treatment of advanced and recurrent malignant genitourinary tumors in children.
Cancer 60:602-611, 1987.
40.
Li FP, Gimbrere K, Gelber RD, Sallan SE, Flamant F, Green DM, Heyn RM, Meadows AT.
Outcome of pregnancy in women irradiated for childhood Wilms' tumor. JAMA 257:216-219,
1987.
41.
Simon JH, Tebbi CK, Freeman AI, Green DM, Brecher ML, Barcos M. Malignant histiocytosis:
Complete remission in two pediatric patients. Cancer 59:1566-1570, 1987.
42.
Tucker MA, D'Angio GJ, Boice JD, Strong LC, Li FP, Stovall M, Stone BJ, Green DM, Lombardi
F, Newton W, Hoover RN, Fraumeni JF Jr. Bone sarcoma linked to radiotherapy and
chemotherapy in children. N Engl J Med 317:588-593, 1987.
GREEN - 7
43.
Simon JH, Tebbi CK, Freeman AI, Brecher ML, Green DM, Sandberg AA. Acute
megakaryoblastic leukemia associated with mosaic Down's syndrome. Cancer 60:2515-2520,
1987.
44.
Green DM, Finklestein JZ, Norkool P, Breslow NE, D'Angio GJ. Severe hepatic toxicity after
treatment with single dose dactinomycin and vincristine. Cancer 62:270-273, 1988.
45.
Li FP, Williams WR, Gimbrere K, Sallan S, Flamant F, Green DM, Heyn RM, Meadows AT.
Heritable fraction of unilateral Wilms' tumor. Pediatrics 81:147-149, 1988.
46.
Jani Sait SN, Brecher ML, Green DM, Sandberg AA. Translocation t(1;22) in congenital acute
megakaryocytic leukemia. Cancer Genet Cytogenet 34:277-280, 1988.
47.
Green DM, Hall B. Pregnancy outcome following treatment during childhood and adolescence for
Hodgkin's disease. Pediatr Hematol Oncol 5:269-277, 1988.
48.
Green DM, Finklestein JZ, Tefft M, Norkool P. Diffuse interstitial pneumonitis after pulmonary
irradiation for metastatic Wilms' tumor. A report from the National Wilms' Tumor Study. Cancer
63:450-453, 1989.
49.
Grundy P, Breslow N, Green DM, Sharples K, Evans A, D'Angio GJ. Prognostic factors for
children with recurrent Wilms' tumor. J Clin Oncol 7:638-647, 1989.
50.
Meadows AT, Obringer AC, Marrero O, Oberlin O, Robison L, Fossati-Bellani F, Green D, Voute
PA, Morris-Jones P, Greenberg M, Baum E, Ruymann F. Second malignant neoplasms following
childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Med Pediatr Oncol
17:477-484, 1989.
51.
Green DM, Hall B, Zevon MA. Pregnancy outcome following treatment for acute lymphoblastic
leukemia during childhood or adolescence. Cancer 64:2335-2339, 1989.
52.
Green DM, Krischer JP, Bell B, Brecher ML, Cushing B, Whitehead VM. Phase I study of a 120hour continuous, intravenous infusion of 5-fluorouracil in pediatric patients with recurrent solid
tumors. Med Pediatr Oncol 18:321-324,1990.
53.
Larsen E, Perez-Atayde A, Green DM, Retik A, Clavell LA, Sallan SE. Surgery only for the
treatment of patients with stage I (Cassady) Wilms' tumor. Cancer 66:264-266, 1990.
54.
Green DM, Norkool P, Breslow N, Finklestein JZ, D'Angio GJ. Severe hepatic toxicity after
treatment with vincristine and actinomycin D using single-dose or divided dose schedule. J Clin
Oncol 8:1525-1530, 1990.
55.
Zevon MA, Neubauer NA, Green DM. Adjustment and vocational satisfaction of patients treated
during childhood or adolescence for acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol
12:454-461, 1990.
56.
Kakati S, Xiao H, Siddiqui SY, Sreekantaiah C, Weier H-UG, Green DM, Fisher JE, Allen JE.
Constitutional extra chromosomal element in a family with Wilms' tumor. Hum Genet 87:183-188,
1991.
57.
Green DM, Zevon MA, Hall B. Achievement of life goals by adult survivors of modern treatment
for childhood cancer. Cancer 67:206-213, 1991.
58.
Green DM, Breslow N, Ii Y, Grundy P, Shochat S, Takashima J, D'Angio GJ. The role of surgical
excision in the management of relapsed Wilms' tumor patients with pulmonary metastases. J
Pediatr Surg 26:728-733, 1991.
GREEN - 8
59.
Green DM, Finkelstein JZ, Breslow NE, Beckwith JB, D'Angio GJ. Remaining problems in the
treatment of patients with Wilms' tumor. Pediatr Clin NA 38:475-488, 1991.
60.
The National Wilms' Tumor Study Committee. Wilms' tumor. Status report 1990. J Clin Oncol
9:877-887, 1991.
61.
Green DM, Zevon MA, Lowrie G, Siegelstein N, Hall B. Congenital anomalies in children of
patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med
325:141-145, 1991.
62.
Green DM, Fernbach DJ, Norkool P, Kollia G, D'Angio GJ. Treatment of Wilms' tumor patients
with pulmonary metastases detected only with computerized tomography. J Clin Oncol 9:17761781, 1991.
63.
Montgomery BT, Kelalis PP, Blute ML, Bergstralh EJ, Beckwith JB, Norkool P, Green DM,
D'Angio GJ. Extended follow-up of bilateral Wilms tumor: Results of the National Wilms Tumor
Study. J Urol 146:514-518, 1991.
64.
Breslow N, Sharples K, Beckwith JB, Takashima J, Kelalis PP, Green DM, D'Angio GJ.
Prognosis in nonmetastatic, favorable histology Wilms' tumor: Results of the Third National
Wilms' Tumor Study. Cancer 68:2345-2353, 1991.
65.
D'Angio GJ, Green D. Invited editorial comment (Preoperative chemotherapy for children with
Wilms' tumor). J Pediatr Surg 26:955-956, 1991.
66.
Green DM, D'Angio GJ. Staging designation for bilateral Wilms' tumor. Med Pediatr Oncol 20:88
(letter), 1992.
67.
Green DM, D'Angio GJ, Kelalis P, Beckwith JB, Breslow NE. The risks associated with prenephrectomy chemotherapy for patients with unilateral Wilms' tumor. Dial Urol 15(5):7-8, 1992.
68.
Bleyer WA, Smith RA, Green DM, DeLaat CA, Lampkin BC, Coltman CA, Brady AM, Simon M,
Krischer JP, Menck HR. Workgroup #1: Long-term care and lifetime follow-up. Cancer 71:2413,
1993.
69.
Meadows AT, Black B, Nesbit ME Jr, Strong LC, Nicholson HA, Green DM, Hays DM, Lozowski
SL. Long-term survival. Clinical care, research, and education. Cancer 71:3213-3215, 1993.
70.
Green DM. Effects of treatment for childhood cancer on vital organ systems. Cancer 71:32993305, 1993.
71.
Green DM, Breslow NE, Beckwith, JB, Norkool P. Screening of children with hemihypertrophy,
aniridia and Beckwith - Wiedemann syndrome in patients with Wilms' tumor. A report from the
National Wilms' Tumor Study. Med Pediatr Oncol 21:188-192, 1993.
72.
Green DM, Breslow NE, Beckwith JB, Takashima J, Kelalis P, D'Angio GJ. The treatment of
patients less than 2 years of age with small, stage I/favorable histology Wilms' tumor. A report
from the National Wilms' Tumor Study. J Clin Oncol 11:91-95, 1993.
73.
Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol
21:172-181, 1993.
74.
D'Angio GJ, Rosenberg H, Sharples K, Kelalis P, Breslow N, Green DM. Position paper: Imaging
methods for primary renal tumors of childhood: Costs versus benefits. Med Pediatr Oncol 21:205212, 1993.
GREEN - 9
75.
Green DM, Breslow NE, D'Angio GJ. The treatment of children with unilateral Wilms' tumor. J
Clin Oncol 11:1009-1010 (editorial), 1993.
76.
Finkelstein JZ, Norkool P, Green DM, Breslow N, D'Angio GJ. Diastolic hypertension in Wilms'
tumor. A late effect of treatment? A report from the National Wilms' Tumor Study Group. Am J
Clin Oncol 16:201-205, 1993.
77.
Ritchey ML, Kelalis PP, Haase GM, Shochat SJ, Green DM, D'Angio GJ. Preoperative therapy
for intracaval and atrial extension of Wilms tumor. Cancer 71:4104-4110, 1993.
78.
Masera G, Spinetta JJ, D'Angio GJ, Green DM, Marky I, Jankovic M, Karamoschoglou LD, Mor
W, Morris-Jones P, Stocker M, Postma A, Nesbit ME, Schuler D, Stevens M, Wilbur J. SIOP
working committee on psychosocial issues in pediatric oncology. Med Pediatr Oncol 21:627-628,
1993.
79.
Green DM, Zevon MA, Reese PA, Lowrie GS, Gaeta JF, Pearce JI, Michalek AM, Stephens EA.
Second malignant tumors following treatment during childhood and adolescence for cancer. Med
Pediatr Oncol 22:1-10, 1994.
80.
Green DM, Zevon MA, Reese PA, Lowrie GS, Michalek A. Factors which influence the further
survival of patients who survive for five years after the diagnosis of cancer in childhood or
adolescence. Med Pediatr Oncol 22:91-96 (correction 1996;26:72), 1994.
81.
Breslow NE, Olshan A, Beckwith B, Moksness J, Feigl P, Green D. Ethnic variation in the
incidence, diagnosis, prognosis and follow-up of children with Wilms tumor. J Natl Cancer Inst
86:49-51, 1994.
82.
Green DM, Breslow NE, Evans I, Moksness J, Finkelstein JZ, Evans AE, D'Angio GJ. The effect
of chemotherapy dose intensity on the hematological toxicity of the treatment for Wilms tumor. A
report from the National Wilms' Tumor Study. Am J Pediatr Hematol Oncol 16:207-212, 1994.
83.
Green DM, Beckwith JB, Weeks DA, Moksness J, Breslow NE, D'Angio GJ. The relationship
between microsubstaging variables, tumor weight and age at diagnosis of children with Stage
I/favorable histology Wilms tumor. A report from the National Wilms Tumor Study. Cancer
74:1817-1820, 1994.
84.
Green DM, Breslow NE, Beckwith JB, Moksness J, Finkelstein JZ, D'Angio GJ. The treatment of
children with clear cell sarcoma of the kidney. A report from the National Wilms Tumor Study
Group. J Clin Oncol 12:2132-2137, 1994.
85.
Green DM, Beckwith JB, Breslow NE, Faria P, Moksness J, Finkelstein JZ, Grundy P, Thomas
PRM, Kim T, Shochat S, Haase G, Ritchey M, Kelalis P, D'Angio GJ. The treatment of children
with stages II - IV anaplastic Wilms tumor. A report from the National Wilms Tumor Study Group.
J Clin Oncol 12:2126-2131, 1994.
86.
Green DM, Edge SB, Penetrante RB, Bakshi S, Shedd D, Zevon MA. In situ breast carcinoma
after treatment during adolescence for thyroid cancer with radioiodine. Med Pediatr Oncol 24:8286, 1995.
87.
Ritchey ML, Green DM, Breslow N, Norkool P, D'Angio GJ. Accuracy of current imaging
modalities in the diagnosis of synchronous bilateral Wilms tumor: A report from the National
Wilms Tumor Study (NWTS) Committee. Cancer 75:600-604, 1995.
88.
Green DM. Treatment of stage I Wilms' tumor. J Clin Oncol 13:1530 (letter), 1995.
89.
Van Hoff J, Grier H, Douglass E, Green D. Etoposide, ifosfamide and cisplatin (VIP) therapy for
refractory childhood solid tumors: Response and toxicity. Cancer 75:2966-2970, 1995.
GREEN - 10
90.
Green DM, Breslow NE, Evans I, Moksness J, Finkelstein JZ, Evans AE, D'Angio GJ. The
relationship between dose schedule and charges for treatment on National Wilms Tumor Study 4. A report from the National Wilms Tumor Study Group. Monogr Natl Cancer Inst 19:21-25,
1995.
91.
Breslow NE, Takashima JR, Whitton JA, Moksness J, D'Angio GJ, Green DM. Second malignant
neoplasms following treatment for Wilms tumor: A report from the National Wilms Tumor Study
Group. J Clin Oncol 13:1851-1859, 1995.
92.
Green DM, Thomas PRM, Shochat S. The treatment of Wilms tumor. Results of the National
Wilms Tumor Studies. Hematol/Oncol Clin NA 9:1267-1274, 1995.
93.
Green DM, Coppes MJ. Future directions in therapeutic research in Wilms tumor. Hematol/Oncol
Clin NA 9:1329-1339, 1995.
94.
Green DM, Donckerwolcke R, Evans AE, D'Angio GJ. Late effects of treatment for Wilms tumor.
Hematol/Oncol Clin NA 9:1317-1327, 1995.
95.
Green DM, Zevon MA, Reese PA, Lowrie GS, Michalek A. Correction to “Factors which influence
the further survival of patients who survive for five years after the diagnosis of cancer in childhood
or adolescence”. Med Pediatr Oncol 26:72, 1996.
96.
Ritchey ML, Green DM, Thomas PRM, Smith GR, Haase G, Shochat S, Moksness J, Breslow
NE. Renal failure in Wilms tumor patients: A report from the National Wilms Tumor Study Group.
Med Pediatr Oncol 26:75-80, 1996.
97.
Green DM, Evans I, Moksness J, D'Angio GJ. The treatment of children with stage IV Wilms
tumor. A report from the National Wilms Tumor Study Group. Med Pediatr Oncol 26:147-152,
1996.
98.
Faria P, Beckwith JB, Kishra K, Zuppan C, Weeks DA, Breslow N, Green DM. Focal versus
diffuse anaplasia in Wilms tumor: New definitions with prognostic significance. A report from the
National Wilms Tumor Study Group. Am J Surg Pathol 20:909-920, 1996.
99.
Frazier AL, Grier HE, Green DM. Successful treatment of endodermal sinus tumor in children
using etoposide, vincristine and cisplatin alternating with vincristine, dactinomycin and
cyclophosphamide (EPO - VAC). Med Pediatr Oncol 27:69-73, 1996.
100.
Li FP, Breslow NE, Morgan JM, Ghahremani M, Miller GA, Grundy PE, Green DM, Diller LR,
Pelletier J. Germline WT1 mutations in Wilms' tumor patients: Preliminary results. Med Pediatr
Oncol 27:404-407, 1996.
101.
Green DM. Commentary on, 'Evaluation and controversies in management of Wilms tumor'.
Oncology 10:1571 (editorial), 1996.
102.
Green DM, Fiorello A, Zevon MA, Hall B, Seigelstein N. Birth defects and childhood cancer in
offspring of survivors of childhood cancer. Arch Pediatr Adolesc Med 151:379-383, 1997.
103.
Ritchey ML, Green DM, Breslow NE, Guthrie KA. Comments on Wilms' tumor experience.
Pediatrics 99:503 (letter), 1997.
104.
Green DM. Wilms tumor. Eur J Cancer 33:409-418, 1997.
105.
Sanders J, Glader B, Cairo M, Finklestein JZ, Forman E, Green D, Luban N, Bleyer WA, Lampkin
BC, Murphy SB, Woods WG. Guidelines for the pediatric cancer center and role of such centers
in diagnosis and treatment. Pediatrics 99:139-141, 1997.
GREEN - 11
106.
Ritchey ML, Green DM, Thomas PRM, Smith GR, Haase G, Shochat S, Moksness J, Breslow
NE. Letter to the Editor: Response to Letter by Cozzi and Schiavetti. Med Pediatr Oncol 28:240
(letter), 1997.
107.
Masera G, Chesler MA, Jankovic M, Ablin AR, Ben Arush MW, Breatnach F, McDowell HP, Eden
T, Epelman C, Fossati Bellani F, Green DM, Kosmidis HV, Nesbit ME, Wandzura C, Wilbur JR,
Spinetta JJ. SIOP Working Committee on Psychosocial Issues in Pediatric Oncology: Guidelines
for communication of the diagnosis. Med Pediatr Oncol 28:382-385, 1997.
108.
Green DM. Fertility and pregnancy outcome after treatment for cancer in childhood or
adolescence. The Oncologist 2:171-179, 1997.
109.
Green DM. Re: Enucleative surgery for stage I nephroblastoma with normal contralateral kidney.
J Urol 158:548-549 (letter), 1997.
110.
Ritchey ML, Green DM, Breslow NE, Guthrie KA. Re: Is contralateral exploration of the kidney
necessary in patients with Wilms tumor? J Urol 158:186 (letter), 1997.
111.
Petruzzi MJ, Green DM. Wilms tumor. Pediatr Clin NA 44:939-952, 1997.
112.
Green D, Breslow N, Beckwith J, Finklestein J, Grundy P, Thomas P, Kim T, Shochat S, Haase
G, Ritchey M, Kelalis P, D'Angio G. A comparison between single dose and divided dose
administration of dactinomycin and doxorubicin. A report from the National Wilms Tumor Study
Group. J Clin Oncol 16:237-245, 1998.
113.
Masera G, Spinetta JJ, Jankovic M, Ablin AR, Buchwall I, Van Dongen-Melman J, Eden T,
Epelman C, Green DM, Kosmidis HV, Yoheved S, Gentil-Martins A, Mor W, Oppenheim D,
Petrelli AS, Schuler D, Topf R, Wilbur JR, Chesler MA. Guidelines for a therapeutic alliance
between families and staff: A report of the SIOP Working Committee on Psychosocial Issues in
Pediatric Oncology. Med Pediatr Oncol 30:183-196, 1998.
114.
Pratt CB, Maurer HM, Gieser P, Salzberg A, Rao BN, Parham D, Thomas PRM, Marcus RB,
Cantor A, Pick T, Green D, Neff J, Jenkins JJ III. Treatment of unresectable or metastatic
pediatric soft tissue sarcomas with surgery, irradiation and chemotherapy: A Pediatric Oncology
Group study. Med Pediatr Oncol 30:201-209, 1998.
115.
Lee RJ, Smith SH, Hicks WL Jr, Iqbal V, Green DM. Management of extraosseous Ewing
sarcoma of the infratemporal fossa. Med Pediatr Oncol 31:31-35, 1998.
116.
Green DM, Gingell RL. Cardiac function and morbidity in long-term survivors of Hodgkin’s
disease. Int J Rad Oncol Biol Phys 41:971 (letter), 1998.
117.
Diller L, Ghahremani M, Morgan J, Reeves C, Breslow N, Green D, Neuberg D, Pelletier J, Li FP.
Frequency of constitutional mutations in the WT1 gene in patients with Wilms tumors. J Clin
Oncol 16:3634-3640, 1998.
118.
Green DM, Breslow NE, Beckwith JB, Finklestein JZ, Grundy P, Thomas PRM, Kim T, Shochat
S, Haase G, Ritchey M, Kelalis P, D'Angio GJ. The effect of duration of treatment on outcome
and cost of the treatment for Wilms tumor. A report from the National Wilms Tumor Study Group.
J Clin Oncol 16:3744-3751, 1998.
119.
Green DM. Second cancer after acute lymphoblastic leukemia. J Clin Oncol 16:3918 (letter),
1998.
120.
Meisel JA, Guthrie KA, Breslow NE, Donaldson SS, Green DM. Significance and management of
computed tomography detected pulmonary nodules. A report from the National Wilms Tumor
GREEN - 12
Study Group. Int J Rad Oncol Biol Phys 44:579-585, 1999.
121.
Shamberger RC, Guthrie KA, Ritchey ML, Haase GM, Takashima J, Beckwith JB, D’Angio GJ,
Green DM, Breslow NE. Surgery-related factors and local recurrence of Wilms tumor in National
Wilms Tumor Study - 4. Ann Surg 229:292-297, 1999.
122.
Pratt CB, Pappo AS, Gieser P, Jenkins JJ, Salzberg A, Neff J, Rao B, Green D, Thomas P,
Marcus R, Parham D, Maurer H. Role of adjuvant chemotherapy in the treatment of surgically
resected pediatric non-rhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology
Group Study. J Clin Oncol 17:1219-1226, 1999.
123.
Coppes MJ, Arnold M, Beckwith JB, Ritchey ML, D’Angio GJ, Green DM, Breslow NE. Factors
affecting the risk of contralateral Wilms tumor development. Cancer 85:1616-1625, 1999.
124.
Breslow NE, Partin AW, Guthrie KA, Beckwith JB, Green DM. Nuclear morphometry and
prognosis in favorable histology Wilms tumor: A prospective reevaluation. J Clin Oncol 17:21232126, 1999.
125.
Choyke PL, Siegel MJ, Craft AW, Green DM, DeBaun MR. Screening for Wilms tumor in children
with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 32:196200, 1999.
126.
Green DM, Hyland A, Chung CS, Zevon MA, Hall BC. Cancer and cardiac mortality among fifteen
year survivors of cancer diagnosed during childhood or adolescence. J Clin Oncol 17:3207-3215,
1999.
127.
Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Gradishar WJ, Green DM,
Langdon RJ Jr, Mitchell RB, Negrin R, Szatrowski TP, Thigpen JT, Von Hoff D, Wasserman TH,
Winer EP, Pfister DG. American Society of Clinical Oncology: Clinical practice guidelines for the
use of chemotherapy and radiotherapy protectants. J Clin Oncol 17:3333-3355, 1999.
128.
Spinetta JJ, Jankovic M, Eden T, Green DM, Gentil Martins A, Wandzura C, Wilbur J, Masera G.
Guidelines for assistance to siblings of children with cancer: Report of the SIOP Working
Committee on Psychosocial Issues in Pediatric Oncology. Med Pediatr Oncol 33:395-398, 1999.
129.
Thandla S, Alashari M, Green DM, Aplan PD. Therapy-related T-cell lymphoblastic lymphoma
with (11;19)(q23;p13) and MLL gene rearrangement. Leukemia 13:2116-2118, 1999.
130.
Shearer PD, Valentine MB, Grundy P, DeCou JM, Banavali SD, Komuro H, Green DM, Beckwith
JB, Look AT. Hemizygous deletions of chromosome band 16q24 in Wilms tumor: Detection by
fluorescence in situ hybridization. Cancer Genet Cytogenet 115:100-105, 1999.
131.
Green DM, Hyland A, Barcos MP, Reynolds JA, Lee RJ, Hall BC, Zevon MA. Second malignant
neoplasms after treatment for Hodgkin disease in childhood or adolescence. J Clin Oncol
18:1492-1499, 2000.
132.
Porteus MH, Norkool P, Neuberg D, Guthrie K, Breslow N, Green DM, Diller L. Characteristics
and outcomes of children with Beckwith-Wiedemann syndrome and Wilms tumor: A report from
the National Wilms Tumor Study Group. J Clin Oncol 18:2026-2031, 2000.
133.
Sklar C, Whitton J, Metens A, Stovall M, Green D, Marina N, Greffe B, Wolden S, Robison L.
Abnormalities of the thyroid in survivors of Hodgkin’s disease: A report from the Childhood
Cancer Survivor Study. J Clin Endocrinol Metab 85:3227-3232, 2000.
134.
Argani P, Perlman EJ, Breslow NE, Browning NG, Green DM, D’Angio GJ, Beckwith JB. Clear
cell sarcoma of the kidney. A review of 351 cases from the National Wilms Tumor Study Group
Pathology Center. Am J Surg Pathol 24:4-18, 2000.
GREEN - 13
135.
Breslow NE, Takashima JR, Ritchey ML, Strong LC, Green DM. Renal failure in the Denys-Drash
and Wilms Tumor-Aniridia syndromes. Cancer Res 60:4030-4032, 2000.
136.
Boice JD Jr, Robison LL, Mertens A, Stovall M, Green DM, Mulvihill JJ. Stillbirths and male
irradiation. J Radiol Prot 20:321-324, 2000.
137.
Amar AM, Tomlinson G, Green DM, Breslow NE, de Alarcon PA. Clinical presentation of
rhabdoid tumors of the kidney. Am J Pediatr Hematol/Oncol 23:105-109, 2001.
138.
Shearer P, Kapoor G, Beckwith JB, Takashima J, Breslow N, Green DM. Secondary acute
myelogenous leukemia in patients previously treated for childhood renal tumors: A report from the
National Wilms Tumor Study Group. Am J Pediatr Hematol/Oncol 23:109-111, 2001.
139.
Green DM, Grigoriev YA, Nan B, Takashima JR, Norkool PA, D’Angio GJ, Breslow NE.
Congestive heart failure after treatment for Wilms’ tumor: A report from the National Wilms’
Tumor Study Group. J Clin Oncol 19: 1926-1934, 2001.
140.
Arroyo MR, Green DM, Perlman EJ, Beckwith JB, Argani P. The spectrum of metanephric
adenofibroma and related lesions: Clinicopathologic study of 25 cases from the National Wilms
Tumor Study Group Pathology Center. Am J Surg Pathol 25:433-444, 2001.
141.
Parham DM, Roloson G, Feely M, Green DM, Bridge JA, Beckwith JB. Primary malignant
neuroepithelial tumors of the kidney. A clinicopathologic analysis of 146 adult and pediatric cases
from the National Wilms’ Tumor Study Pathology Center. Am J Surg Pathol 25:133-146, 2001.
142.
Shamberger RC, Ritchey ML, Haase GM, Bergemann TL, Loechelt-Yoshioka T, Breslow NE,
Green DM. Intravascular extension of Wilms tumor. Ann Surg 234:116-121, 2001.
143.
Green DM, Breslow NE, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D’Angio GJ,
Perlman E, Donaldson M, Grundy PE, Weetman R, Coppes MJ, Malogolowkin M, Shearer P,
Coccia P, Kletzel M, Thomas PRM, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D.
Treatment with nephrectomy only for small, stage I/favorable histology Wilms tumor. A report
from the National Wilms Tumor Study Group. J Clin Oncol 19:3719-3724, 2001.
144.
Green DM. Preserving fertility in children treated for cancer. Br Med J 323:1201 (editorial), 2001.
145.
Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Li FP, Meadows AT,
Mulvihill JJ, Neglia JP, Nesbit ME, Packer RJ, Potter JD, Sklar CA, Smith MA, Stovall M, Strong
LC, Yasui Y, Zeltzer LK. Study design and cohort characteristics of the Childhood Cancer
Survivor Study: A multi-institutional collaborative project. Med Pediatr Oncol 38:229-239, 2002
146.
Green DM, Peabody EM, Tait PP, Norkool PA, Breslow NE. Pregnancy outcome after treatment
for Wilms tumor. A report from the National Wilms Tumor Study Group. J Clin Oncol 20:25062513, 2002.
147.
Green DM. Use of chest computed tomography for staging and treatment of Wilms’ tumor in
children. J Clin Oncol 20: 2763-2764 (editorial), 2002.
148.
Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB, Pendergrass TW,
Robison LL. Pregnancy outcome of female survivors of childhood cancer. A report from the
Childhood Cancer Survivor Study. Am J Obstet Gynecol 187:1070-1080, 2002.
149.
Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB, Pendergrass TW,
Robison LL. Pregnancy outcome of partners of male survivors of childhood cancer. A report from
the Childhood Cancer Survivor Study. J Clin Oncol 21:716-721, 2003.
GREEN - 14
150.
Green DM. Pediatric Update. Commentary. Eur J Cancer 38:1645-1646, 2003.
151.
Green DM. Pediatric Update. Commentary. Eur J Cancer 38:1251-1253, 2003.
152.
Boice JD Jr, Tawn EJ, Winther JF, Donaldson SS, Green DM, Mertens AC, Mulvihill JJ, Olsen
JH, Robison LL, Stovall M. Genetic effects of radiotherapy for childhood cancer. Health Phys 85
(1):65-80, 2003.
153.
Green DM. Grigoriev YA, Nan B, Takashima JR, Norkool PA, D’Angio GJ, Breslow NE.
Correction to “Congestive heart failure after treatment for Wilms’ tumor”. J Clin Oncol 21: 24472448, 2003.
154.
Green DM. Late effects of treatment for cancer during childhood and adolescence. Curr Prob
Cancer 27:127-142, 2003.
155.
Breslow NE, Norris R, Norkool PA, Tang T, Beckwith JB, Perlman EJ, Ritchey ML, Green DM,
Nichols K. Characteristics and outcomes of children with the Wilms tumor-aniridia syndrome: A
report from the National Wilms Tumor Study Group. J Clin Oncol 21:4579-4585, 2003.
156.
Kalapurakal JA, Li SM, Breslow NE, Beckwith JB, Macklis R, Thomas PR, D'Angio GJ, Kim T, de
Lorimier A, Kelalis P, Shochat S, Ritchey M, Haase G, Hrabovsky E, Otherson HB, Grundy P,
Green DM. National Wilms' Tumor Study Group. Influence of radiation therapy delay on
abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3
and NWTS-4: A report from the National Wilms' Tumor Study Group. Int J Rad Oncol Biol Phys
57:495-499, 2003.
157.
Blakely ML, Shamberger RC, Norkool P, Beckwith JB, Green DM, Ritchey ML. National Wilms'
Tumor Study Group. Outcome of children with cystic partially differentiated nephroblastoma
treated with or without chemotherapy. J Pediatr Surg 38:897-900, 2003.
158.
Seibel NL, Li S, Breslow NE, Beckwith JB, Green DM, D'Angio GJ, Ritchey ML, Thomas PRM,
Grundy PE, Finklestein JZ, Kim T, Shochat SJ, Haase GM, Kelalis PP. Effect of duration of
treatment on treatment outcome for patients with clear cell sarcoma of the kidney: A report from
the National Wilms’ Tumor Study Group. 22:468-473, 2004.
159.
Green DM. The treatment of stages I – IV favorable histology Wilms tumor. J Clin Oncol 22:13661372, 2004.
160.
Kalapurakal JA, Peterson S, Peabody EM, Thomas PRM, Green DM, D’Angio GJ, Breslow NE.
Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood
Wilms tumor survivors: A report from the National Wilms Tumor Study. Int J Rad Oncol Biol Phys
58:1364-1368, 2004.
161.
Breslow NE, Ou S-S, Beckwith JB, Haase GM, Kalapurakal JA, Ritchey ML, Shamberger RC,
Thomas PRM, D’Angio GJ, Green DM. Doxorubicin for favorable histology, stage II – III Wilms
tumor: Results from the National Wilms Tumor Studies. Cancer 101:1072-1080, 2004.
162.
Boice JD Jr, Stovall M, Mulvihill JJ, Green DM. Dental x-rays and low birth weight. J Radiol
Protect 24:321-325, 2004.
163.
Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, Darling J, Armstrong FD,
Blatt J, Constine LS, Freeman CR, Friedman DL, Green DM, Marina N, Meadows AT, Neglia JP,
Oeffinger KC, Robison LL, Ruccione KS, Sklar CA, Hudson MM. Development of risk-based
guidelines for pediatric cancer survivors: the Children’s Oncology Group long-term follow-up
guidelines from the Children’s Oncology Group Late Effects Committee and Nursing Discipline. J
Clin Oncol 22:4979-4990, 2004.
GREEN - 15
164.
Kalapurakal JA, Nan B, Norkool P, Coppes M, Perlman E, Beckwith B, Ritchey M, Breslow N,
Grundy P, D'Angio GJ, Green DM, Thomas PRM. Treatment outcomes in adults with favorable
histologic type Wilms tumor-an update from the National Wilms Tumor Study Group. Int J Rad
Oncol Biol Phys 60:1379-84, 2004.
165.
Ehrlich PF, Ritchey ML, Hamilton TE, Haase GM, Ou S, Breslow N, Grundy P, Green D, Norkool
P, Becker J, Shamberger RC. Quality assessment for Wilms’ tumor: A report from the National
Wilms’ Tumor Study – 5. J Pediatr Surg 40:208-213, 2005.
166.
Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM. End stage renal
disease in patients with Wilms tumor: Results from the National Wilms Tumor Study Group and
the United States Renal Data System. J Urol 174:1972-1975, 2005.
167.
Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM,
D’Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PRM, Macklis R,
Tomlinson G, Huff V, Green DM. Loss of heterozygosity for chromosomes 1p and 16q is an
adverse prognostic factor in favorable histology Wilms tumor. A report from the National Wilms
Tumor Study Group. J Clin Oncol 23:7312-7321, 2005.
168.
Robison LL, Green DM, Hudson M, Meadows AT, Mertens AC, Packer RJ, Sklar CA, Strong LC,
Yasui Y, Zeltzer LK. Long-term outcomes of adult survivors of childhood cancer: Results from the
Childhood Cancer Survivor Study. Cancer 104:2557-2564, 2005.
169.
Tomlinson GE, Breslow NE, Dome J, Guthrie KA, Norkool P, Li S, Thomas PRM, Perlman E,
Beckwith JB, D'Angio GJ, Green DM. Rhabdoid tumor of the kidney in the National Wilms' Tumor
Study: Age at diagnosis as a prognostic factor. J Clin Oncol 23: 7641–7645, 2005.
170.
Dome JS, Bockhold CA, Li SM, Baker SD, Green DM, Perlman EJ, Hill DA, Breslow NE.
Telomerase RNA (TERC/hTR) expression as a prognostic marker for favorable histology Wilms
tumor. J Clin Oncol 23:9138-9145, 2005.
171.
Perlman EJ, Faria P, Soares A, Hoffer F, Sredni S, Ritchey M, Shamberger RC, Green D,
Beckwith JB. Hyperplastic perilobar nephroblastomatosis: Long term survival of 52 patients.
Pediatr Blood Cancer 46:203-221, 2006.
172.
Shamberger RC, Haase GM, Argani P, Perlman EJ, Cotton CA, Takashima J, Green DM,
Ritchey ML. Bilateral Wilms tumors with progressive or nonresponsive disease. J Pediatr Surg
41:652-657, 2006.
173.
Breslow NE, Beckwith JB, Haase GM, Kalapurakal JA, Ritchey ML, Shamberger RC, Thomas
PRM, D’Angio GJ, Green DM. Radiation therapy for favorable histology Wilms tumor: Prevention
of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4. Int J Rad
Oncol Biol Phys 65:203-209, 2006.
174.
Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE,
Malogolowkin MH, Beckwith JB, Shamberger RS, Haase GM, Coppes MJ, Coccia P, Kletzel M,
Weetman RM, Donaldson M, Macklis RM, Green DM. Treatment of anaplastic histology Wilms
tumor: Results from the Fifth National Wilms Tumor Study. J Clin Oncol 24:2352-2358, 2006.
175.
Sklar CA. Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson
HS, Yasui Y, Robison LL. Premature menopause in survivors of childhood cancer: A report from
the Childhood Cancer Survivor Study. J Natl Cancer Inst 98:890-896, 2006.
176.
Signorello LB, Cohen SS, Bosetti C, Stovall M, Kasper CE, Weathers RE, Whitton JA, Green DM,
Donaldson SS, Mertens AC, Robison LL, Boice JD Jr. Female survivors of childhood cancer:
preterm birth and low birth weight among their children. J Natl Cancer Inst 98:1453-1461, 2006.
GREEN - 16
177.
Hamilton TE, Green D, Perlman E, Argani P, Grundy P, Ritchey ML, Shamberger RC. Bilateral
Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study. J Pediatr Surg
41:1641-1644, 2006.
178.
Lawless SCW, Verma P, Green DM, Mahoney MC. Mortality experiences among 15+ year
survivors of childhood and adolescent cancers. Pediatr Blood Cancer 48:333-338, 2007.
179.
Green DM, Cotton CA, Malogolowkin M, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas
PRM, Grundy PE, D’Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M,
Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V,
Newbury R, Weeks D. Treatment of Wilms tumor relapsing after initial treatment with vincristine
and actinomycin D. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer
48:493-499, 2007.
180.
Green DM. Controversies in the management of Wilms tumour - immediate nephrectomy or
delayed nephrectomy? Eur J Cancer 43:2453-2456, 2007.
181.
Feusner JH, Ritchey ML, Norkool PA, Takashima JR, Breslow NE, Green DM. Renal failure does
not preclude cure in children receiving chemotherapy for Wilms tumor: A report from the National
Wilms Tumor Study Group. Pediatr Blood Cancer 50:242-245, 2008.
182.
Malogolowkin M, Cotton CA, Green DM, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas
PRM, Grundy PE, D’Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M,
Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V,
Newbury R, Weeks D. Treatment of Wilms tumor relapsing after initial treatment with vincristine,
actinomycin D and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr
Blood Cancer 50:236-241, 2008.
183.
Mulrooney DA, Ness KK, Neglia JP, Whitton J, Green DM, Zeltzer LK, Robison LL, Mertens AC.
Fatigue and sleep disturbance in adult survivors of childhood cancer: Lack of clinically important
differences. A report from the Childhood Cancer Survivor Study (CCSS). Sleep 31:271-281,
2008.
184.
Green, DM. Chemotherapy for the treatment of children and adolescents with malignant germ cell
tumors. J Clin Oncol 26:3297-3298, 2008.
185.
Jones DP, Spunt SL, Green D, Springate JE. Renal late effects in patients treated for cancer in
childhood: A report from the Children’s Oncology Group. Pediatr Blood Cancer 51:724-731, 2008.
186.
Hensley ML, Hagerty KL, Kewalramani T, Green DM, NJ, Wasserman TH, Cohen GI, Emami B,
Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A, III, von Hoff D, Schuchter LM. American Society
of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and
Radiation Therapy Protectants. J Clin Oncol 27:127-145, 2009.
187.
Cotton CA, Peterson S, Norkool PA, Takashima J, Grigoriev Y, Green DM, Breslow NE. Early
and late mortality after diagnosis of Wilms tumor. J Clin Oncol 27:1304-1309, 2009.
188.
Fernandez CV, Anderson J, Breslow N, Dome JS, Grundy P, Perlman E, Green DM.
Anthropomorphic measurements and event free survival in patients with favorable histology
Wilms tumor: A report from the Children’s Oncology Group. Pediatr Blood Cancer 52:254-258,
2009.
189.
Huang CC, Gadd S, Breslow N, Cutcliffe C, Sredni ST, Helenowski IB, Dome JS, Grundy PE,
Green DM, Fritsch MK, Perlman EJ. Predicting relapse in favorable histology Wilms tumor using
gene expression analysis: A report from the Renal Tumor Committee of the Children's Oncology
Group. Clin Cancer Res 15:1770-1778, 2009.
GREEN - 17
190.
Green DM, Sklar CA, Boice JD Jr., Mulvihill JJ, Whitton JA, Stovall M, Yasui Y. Ovarian failure
and reproductive outcomes after childhood cancer treatment. Results from the Childhood Cancer
Survivor Study. J Clin Oncol 27:2374-2381, 2009.
191.
Hudson MM, Mulrooney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, Oeffinger KC,
Neglia JP, Meadows AT, Robison LL. High risk populations identified in Childhood Cancer
Survivor Study investigations: Implications for risk-based surveillance. J Clin Oncol 27:2405–
2414, 2009.
192.
Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, Green DM,
Hammond S, Meadows AT, Mertens AC, Mulvihill JJ, Nathan PC, Neglia JP, Packer RJ,
Rajaraman P, Sklar CA, Stovall M, Strong LC, Yasui Y, Zeltzer LK. The Childhood Cancer
Survivor Study: A National Cancer Institute supported resource for outcome and intervention
research. J Clin Oncol 27:2308–2318, 2009.
193.
Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne
J, Robison LL. Fertility of female survivors of childhood cancer. A report from the Childhood
Cancer Survivor Study. J Clin Oncol 27:2677-2685, 2009.
194.
Wright KD, Green DM, Daw NJ. Late effects of treatment for Wilms tumor. Pediatr Hematol Oncol
26:407-413, 2009.
195.
Sredni ST, Gadd S, Huang C-C, Breslow N, Grundy P, Green DM, Dome JS, Shamberger RC,
Beckwith JB, Perlman EJ. Subsets of very low risk Wilms tumors show distinctive gene
expression, histologic, and clinical features. Clin Cancer Res 15:6800-6809, 2009.
196.
Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, Donaldson SS,
Green DM, Sklar CA, Robison LL Leisenring WM. Cardiac outcomes in a cohort of adult survivors
of childhood and adolescent cancer: A report from the Childhood Cancer Survivor Study. Br Med
J 339:b4606, 2009.
197.
Klosky JL, Gamble HL, Spunt SS, Randolph-Frye ME, Green DM, Hudson MM, Human
papillomavirus (HPV) vaccination in survivors of childhood cancer. Cancer 115:5627-5636, 2009.
198.
Ehrlich PF, Ferrer FA, Ritchey ML, Anderson JR, Green DM, Grundy PE, Dome JS, Kalapurakal
JA, Perlman EJ, Shamberger RC. Hepatic metastasis at diagnosis in patients with Wilms tumor is
not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the
Children's Oncology Group/National Wilms Tumor Study Group. Ann Surg 250(4):642-648, 2009.
199.
Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne
J, Robison LL. Fertility of male survivors of childhood cancer. A report from the Childhood Cancer
Survivor Study. J Clin Oncol 28:332-339, 2010.
200.
Kalapurakal JA, Li SM, Breslow NE, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM,
Thomas PRM, Grundy P, Green DM, D'Angio GJ. Intraoperative spillage of favorable histology
Wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence.
A report from the National Wilms Tumor Study Group. Int J Rad Oncol Biol Phys 76:201-206,
2010.
201.
Warwick AB, Kalapurakal JA, , Ou S-S, Green DM, Norkool PA, Peterson SM, Breslow NE Portal
hypertension in children with Wilms tumor: A report from the National Wilms Tumor Study Group.
Int J Radiat Oncol Biol Phys 77:210, 2010.
202.
Breslow NE, Lange JM, Friedman DL, Green DM, Hawkins MM, Murphy MFG, Neglia JP, Olsen
JH, Peterson SM, Stiller CA, Robison LL. Secondary malignant neoplasms following Wilms
tumor: An international collaborative study. Int J Cancer 127:657-666, 2010.
GREEN - 18
203.
Shamberger RC, Anderson JR, Breslow NE, Perlman EJ, Beckwith JB, Ritchey ML, Haase GM,
Donaldson M, Grundy PE, Weetman R, Coppes MJ, Malogolowkin M, Shearer PD, Kletzel M,
Thomas PRM, Macklis R, Huff V, Weeks DA, Green DM. Long-term outcomes of infants with very
low risk Wilms tumor treated with surgery alone on National Wilms Tumor Study -5. Ann Surg
251:555-558, 2010.
204.
Green DM, Lange J, Peabody, EM, Grigoreiva NN, Peterson S, Kalapurakal JA, Breslow NE.
Pregnancy outcome after treatment for Wilms tumor: A report from the National Wilms Tumor
Long-Term Follow-Up Study. J Clin Oncol 28:2824-2830, 2010.
205.
Signorello LB, Mulvihill JJ, Green DM, Munro HM, Stovall M, Weathers RE, Mertens AC, Whitton
JA, Robison LL, Boice JD Jr. Stillbirth and neonatal death in relation to pre-conception radiation
exposure in the Childhood Cancer Survivor Study cohort. Lancet 376:624-630, 2010.
206.
Kalapurakal JA, Green DM, Haase G, Anderson JR, Dome JS, Grundy PE. Outcomes of children
with favorable histology Wilms tumor and peritoneal implants treated in National Wilms Tumor
Studies-4 and -5. Int J Radiat Oncol Biol Phys 77:554-558, 2010.
207.
Hudson MM, Ness KK, Nolan VG, Armstrong GT, Green DM, Morris EB, Spunt SS, Metzger ML,
Krull KK, Klosky J, Srivastava DK, Robison LL. Prospective medical assessment of adults
surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St. Jude
Lifetime Cohort Study. Pediatr Blood Cancer 56:825-836, 2011.
208.
Perlman EJ, Grundy P, Anderson JR, Jennings LJ, Green DM, Dome JS, Shamberger RC,
Ruteshouser EC, Huff V. WT1 mutation and 11p15 loss of heterozygosity predict relapse in very
low risk Wilms tumors treated by surgery alone. J Clin Oncol 29:698-703, 2011.
209.
Hamilton TE, Ritchey ML, Haase GM, Argani P, Peterson SM, Anderson JR, Green DM,
Shamberger RC. The management of synchronous bilateral Wilms tumor: A Report from the
National Wilms Tumor Study Group. Ann Surg 253:1004–1010, 2011.
210.
Termuhlen AM, Tersak JM, Liu Q, Yasui Y, Stovall M, Weathers R, Deutsch M, Sklar CA,
Oeffinger KC, Armstrong G, Robison LL, Green DM. Twenty-five year follow-up of childhood
Wilms tumor. A Report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer
57:1210-1216, 2011.
211.
Lange J, Peterson SM, Takashima JR, Grivoriev Y, Ritchey ML, Shamberger RC, Beckwith JB,
Perlman E, Green DM, Breslow NE. Risk factors for end stage renal disease in non-WT1syndromic Wilms tumor. J Urol 186:378-386, 2011.
212.
Green DM, Nolan VG, Kawashima T, Stovall M, Donaldson SS, Srivastava D, Leisenring W,
Robison LL, Sklar CA. Decreased risk of pregnancy among female childhood cancer survivors
who received 22 to 27 Gy hypothalamic/pituitary irradiation. A report from the Childhood Cancer
Survivor Study. Fertil Steril 95:1922-1927, 2011.
213.
Child CJ, Zimmermann AG, Woodmansee WW, Green DM, Li JJ, Jung H, Erfurth EM, Robison
LL. Assessment of primary cancers in growth hormone-treated adult hypopituitary patients: an
analysis from the Hypopituitary Control and Complications Study (HypoCCS). Eur J Endocrinol
165:217-223, 2011.
214.
Signorello LB, Mulvihill JJ, Green DM, Munro HM, Stovall M, Weathers RE, Mertens AC, Whitton
JA, Robison LL, Boice JD Jr. Congenital anomalies in the children of cancer survivors: A report
from the Childhood Cancer Survivor Study. J Clin Oncol 30:239-245, 2012.
215.
Green DM, Cox CL, Zhu L, Srivastava DK, Stovall M, Nolan VG, Ness KK, Donaldson SS,
Oeffinger KC, Meacham LR, Sklar CA, Krull KR, Armstrong GT, Robison LL. Risk factors for
GREEN - 19
obesity in adult survivors of childhood cancer. A report from the Childhood Cancer Survivor
Study. J Clin Oncol 30:246-255, 2012.
216.
Ness KK, Hudson MM, Pui C-H, Green DM, Krull, KK Huang TT, Robison LR, Morris EB.
Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia:
associations with physical performance and chemotherapy doses. A report from the St, Jude
Lifetime Cohort Study. Cancer 118:828-838, 2012.
217.
Hudson MM, Neglia JP, Woods WG, Sandlund JT, Pui CH, Kun LE, Robison LL, Green DM.
Lessons from the past: Opportunities to improve childhood cancer survivor care through
outcomes investigations of historical therapeutic approaches for pediatric hematological
malignancies. Pediatr Blood Cancer 58:334-343, 2012.
218.
Motosue MM, Zhu L, Srivastava K, Stokes DC, Hudson MM, McPherson V, Srinivasan S, Krasin
MJ, Green DM, Spunt SK, Inaba H. Pulmonary function after whole lung irradiation in pediatric
patients with solid malignancies. Cancer 118:1450-1456, 2012.
219.
Grigoriev Y, Lange J, Peterson SM, Takashima JR, Ritchey ML, Ko D, Feusner JH, Shamberger
RC, Green DM, Breslow NE. Treatments and outcomes for end stage renal disease following
Wilms tumor. Pediatr Nephrol 27(8):1325-33, 2012.
220.
Kieran K, Anderson JR, Dome JS, Ehrlich PF, Ritchey ML, Shamberger RC, Perlman EJ, Green
DM, Davidoff AM. Lymph node involvement in Wilms tumor: results from National Wilms Tumor
Studies 4 and 5. J Pediatr Surg 47:700-6, 2012
221.
Wilson CL, Dilley K, Ness KK, Leisenring WL, Sklar CA, Kaste SC, Stovall M, Green DM,
Armstrong GT, Robison LL, Kadan-Lottick NS. Fractures among long-term survivors of childhood
cancer: A report from the Childhood Cancer Survivor Study. Cancer 118:5920-8201, 2012.
222.
Kenney LB, Cohen LE, Shnorhavorian M, Metzger M, Lockhart B, Hijiya N, Duffey-Lind E,
Constine L, Green D, Meacham L. Male reproductive health after childhood, adolescent, and
young adult cancer: a report from the Children's Oncology Group. J Clin Oncol 30:3408-16, 2012.
223.
Armstrong GT, Plana JC, Zhang N, Srivastava D, Green DM, Ness KK, Donovan FD, Metzger
ML, Arevalo A, Durand J-B, Joshi V, Hudson MM, Robison LL, Flamm S. Screening adult
survivors of childhood cancer for cardiomyopathy: Comparison of echocardiography and cardiac
MRI. J Clin Oncol 30:2876-2884, 2012.
224.
Gadd S, Huff V, Huang CC, Ruteshouser EC, Dome JS, Grundy PE, Breslow N, Jennings L,
Green DM, Beckwith JB, Perlman EJ. Clinically relevant subsets identified by gene expression
patterns support a revised ontogenic model of Wilms tumor: A Children's Oncology Group Study.
Neoplasia 14:742-56, 2012.
225.
Grundy PE, Green DM, Dirks AC, Berendt AE, Breslow NE, Anderson JR, Dome JS. Clinical
significance of pulmonary nodules detected by CT and not CXR in patients treated for favorable
histology Wilms tumor on National Wilms Tumor Studies-4 and -5: A report from the Children's
Oncology Group. Pediatr Blood Cancer 59:631-5, 2012.
226.
Krull KR, Sabin ND, Reddick WE, Zhu L, Armstrong GT, Green DM, Arevalo AR, Krasin MJ,
Srivastava DK, Robison LL, Hudson MM. Neurocognitive function and CNS integrity in adult
survivors of childhood Hodgkin lymphoma. J Clin Oncol 30:3618-24, 2012.
227.
Green DM. Robert E. Gross Lecture - The evolution of treatment for Wilms tumor. J Pediatr Surg
48:14-19, 2013.
GREEN - 20
228.
Brinkman TM, Zhang N, Ullrich NJ, Brouwers P, Green DM, Srivastava DK, Zeltzer LK, Stovall
M, Robison LL, Krull KR. Psychoactive medication use and neurocognitive function in adult
survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Pediatr Blood
Cancer 60:486-493, 2013.
229.
Armstrong GT, Joshi VM, Zhu L, Srivastava D, Zhang N, Ness KK, Stokes DC, Krasin MT, Fowler
JA, Robison LL, Hudson MM, Green DM. Elevated tricuspid regurgitant jet velocity by Doppler
echocardiography in adult survivors of childhood cancer: A report from the St. Jude Lifetime
Cohort Study. J Clin Oncol 31:774-781, 2013.
230.
Ehrlich PF, Anderson JR, Ritchey M, Dome JS, Green DM, Grundy P, Perlman EJ, Kalapurakal
JA, Breslow NE, Shamberger R. Clinico-pathologic findings predictive of relapse in children with
stage III favorable histology Wilms tumor. J Clin Oncol 31:1196-1201, 2013.
231.
Green DM, Zhu L, Zhang N, Sklar CA, Ke RW, Kutteh WH, Klosky JL, Spunt SS, Metzger ML,
Navid F, Srivastava D, Robison LL, Hudson MM. Lack of specificity of plasma concentrations of
inhibin b and follicle-stimulating hormone for identification of azoospermic survivors of childhood
cancer: A report from the St. Jude Lifetime Cohort Study. J Clin Oncol 31:1324-1328, 2013.
232.
Metzger ML, Meacham L, Patterson B, Casillas JS, Constine LS, Hijiya N, Kenney LB, Leonard
M, Lockart BA, Likes W, Green DM. Female reproductive health after childhood, adolescent and
young adult cancer: guidelines for the assessment, and management of female reproductive
complications. J Clin Oncol 31:1239-1247, 2013.
233.
Green DM, Kun LE, Matthay KK, Meadows AT, Meyer WH, Meyers PA, Spunt SL, Robison LL,
Hudson MM. Relevance of historical therapeutic approaches to the contemporary treatment of
pediatric solid tumors. Pediatr Blood Cancer 60:1083-1094, 2013.
234.
Ojha R, Gurney J, Green DM. Clinical prediction models for anthracycline-associated
cardiotoxicity among pediatric cancer survivors – Ready for prime time? Pediatr Blood Cancer
60:1245-1246, 2013 (Invited Commentary)
235.
Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KK, Green DM,
Armstrong GT, Nottage KA, Jones KE, Sklar CA, Srivastava DK, Robison LL. Clinical
ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309:23712381, 2013.
236.
Kieran K, Anderson JR, Dome JS, Ehrlich PF, Ritchey ML, Shamberger RC, Perlman EJ, Green
DM, Davidoff AM. Is adrenalectomy necessary during unilateral nephrectomy for Wilms tumor? A
report from the Children's Oncology Group. J Pediatr Surg 48:1598–1603, 2013.
237.
Green DM, Lange JM, Qu A, Peterson SM, Kalapurakal JA, Stokes DC, Grigoriev YA, Takashima
JR, Norkool P, Friedman DL, Breslow NE. Pulmonary disease after treatment for Wilms tumor: A
report from the National Wilms Tumor Long-Term Follow-Up Study. Pediatr Blood Cancer
60:1721–1726, 2013
238.
Brinkman TM, Ullrich NJ, Zhang N, Green DM, Zeltzer LK, Lommel KM, Brouwers P, Srivastava
DK, Jain N, Robison LL, Krull KR. Prevalence and predictors of prescription psychoactive
medication use in adult survivors of childhood cancer: a report from the Childhood Cancer
Survivor Study. J. Cancer Surviv. 7:104-14, 2013.
239.
Green DM. Evaluation of renal function after successful treatment for unilateral, non-syndromic
Wilms tumor. Pediatr Blood Cancer 60:1929-1935, 2013.
240.
Klosky JL , Russell KM, Canavera KE, Gammel HL, Hodges JR, Foster RH, Parra GR, Simmons
JL, Green DM, Hudson MM. Risk factors for non-initiation of the human papillomavirus (HPV)
vaccine among adolescent survivors of childhood cancer. Cancer Prevention Research 6:1101-
GREEN - 21
1110, 2013.
241.
Green DM, Breslow NE, D’Angio GJ, Malogolowkin MH, Ritchey ML, Evans AE, Beckwith JB,
Perlman EJ, Shamberger RC, Peterson S, Grundy PE, Dome JS, Thomas PRM, Kalapurakal JA.
Outcome of patients with stage II/favorable histology Wilms tumor with and without local tumor
spill. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 61:134–139,
2014.
242.
Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava DK, Leisenring WM, Neglia JP, Sklar
CA, Kaste SC, Hudson MM, Diller LR, Stovall M, Donaldson SS, Robison LL. The
cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure. A
report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 61:53–67, 2014.
243.
Ness KK, Krull KK, Jones KE, Mulrooney DA, Armstrong GT, Green DM, ChemaitillyW, Smith
WA, Wilson CL, Sklar CA, Shelton K, Srivastava DK, Ali S, Robison LL, Hudson MM. Physiologic
frailty as a sign of accelerated aging among adult survivors of childhood cancer: A Report from
the St. Jude Lifetime Cohort Study. J Clin Oncol (in press).
244.
Huang TT, Chen Y, Dietz AC, Yasui Y, Donaldson SS, Stokes DC, Leisenring WM, Sklar CA,
Diller LR, Mertens AC, Armstrong GT, Green DM, Robison LL, Ness KK. Pulmonary outcomes in
survivors of childhood central nervous system malignancies: A Report from the Childhood
Cancer Survivor Study. Pediatr Blood Cancer (in press).
245.
Smith WA, Ness KK, Joshi V, Hudson MM, Robison LL, Green DM. Exercise training in childhood
cancer survivors with subclinical cardiomyopathy who were treated with anthracyclines. Pediatr
Blood Cancer (iin press).
246.
DeWire M, Green DM, Sklar CA, Merchant TE, Wallace D, Lin T, Vern-Gross T, Kun LE, Krasin
MJ, Boyett JM, Wright KD, Wetmore CJ, Broniscer A, Gajjar A. Pubertal development and
ovarian dysfunction in survivors of embryonal brain tumors following risk- adapted craniospinal
irradiation and adjuvant chemotherapy. Pediatr Blood Cancer (submitted).
Books, Book Chapters, and Book Reviews
1.
Rosenberg RD, Green DM. The hemostatic process and malignant disease. In: Holland JF, Frei
E (editors). Cancer Medicine (2nd Edition). Philadelphia: Lea and Febiger, 1326-1338, 1982.
2.
Freeman AI, Weinberg V, Green DM, Brecher ML. Intermediate dose methotrexate (IDM) for the
treatment of childhood acute lymphocytic leukemia (ALL). In: Mathe G, Mihich E, Reizenstein P
(editors). Current Drugs and Methods of Cancer Treatment. New York: Masson Publishing USA,
Inc, 91-99, 1983.
3.
Green DM. Diagnosis and Management of Malignant Solid Tumors in Infants and Children.
Boston: Martinus Nijhoff Publishing, 1-552, 1985.
4.
D'Angio GJ, Beckwith JB, Breslow N, Finklestein J, Green DM, Kelalis P. Wilms' tumor
(nephroblastoma, renal embryoma). In: Pizzo PS, Poplack DG (editors). Principles and Practice
of Pediatric Oncology. Philadelphia: JB Lippincott Company, 583-606, 1988.
5.
Green DM. Long Term Complications of Treatment for Cancer During Childhood and
Adolescence. Baltimore: Johns Hopkins University Press, 1-165, 1989.
6.
Green DM, D'Angio GJ (editors). Late Effects of Treatment for Childhood Cancer. New York:
John Wiley and Sons, 1-186, 1991.
GREEN - 22
7.
Green DM, D'Angio GJ. Wilms' tumor. In: Holland JF, Frei E III, Bast RC, Kufe DW, Morton DL,
Weichselbaum RR (editors). Cancer Medicine (3rd Edition). Philadelphia: Lea and Febiger, 22072218, 1992.
8.
Green DM, D'Angio GJ, Beckwith JB, Breslow N, Finklestein J, Kelalis P, Thomas PRM. Wilms'
tumor (nephroblastoma, renal embryoma). In: Pizzo PS, Poplack DG (editors). Principles and
Practice of Pediatric Oncology (2nd Edition). Philadelphia: JB Lippincott Company, 713-737,
1993.
9.
Bricker GT, Green DM, D'Angio GJ (editors). Cardiac Toxicity After Treatment for Childhood
Cancer. New York: John Wiley and Sons, 1-133, 1993.
10.
Green DM. Commentary on 'Long-term survivors of leukemia treated in infancy: Factors
associated with neuropsychological status. In: Stockman JA III (editor). The Yearbook of
Pediatrics 1994. Saint Louis: Mosby, 383-384, 1994.
11.
Green DM, D’Angio GJ. Induced Malignancies. In: Abeloff MD, Armitage JO, Lichter AS,
Niederhuber JE (editors). Clinical Oncology. New York: Churchill Livingstone, 833-847, 1995.
12.
Green DM, D'Angio GJ, Beckwith JB, Breslow NE, Grundy PE, Ritchey ML, Thomas PRM. The
Biology and Management of Wilms Tumor. In: Rhagavan D, Scher HI, Leibel SA, Lange P
(editors). Principles and Practice of Genitourinary Oncology. Philadelphia: J.B. Lippincott
Company, 1115-1129, 1996.
13.
Green DM, Breslow NE, Grundy PE, Ritchey ML, Thomas PRM. Renal Tumors of Children. In:
Holland JF, Frei E III, Bast RC Jr, Kufe DW, Morton DL, Weichselbaum RR (editors). Cancer
Medicine (4th Edition). Baltimore: Williams & Wilkins, 3047-3058, 1996.
14.
Green DM, Tarbell NJ, Shamberger RC. Solid Tumors of Childhood. In: DeVita VT Jr., Hellman
S, Rosenberg SA (editors). Cancer. Principles and Practice of Oncology (5th Edition).
Philadelphia: J.B. Lippincott, 2091-2130, 1996.
15.
Green DM. Late Effects of Adjuvant Chemotherapy for the Treatment of Cancer in Children and
Adolescents. In: Salmon SE (editor). Adjuvant Therapy of Cancer VIII. Philadelphia: Lippincott Raven, 33-50, 1997.
16.
Green DM, Coppes MJ, Breslow NE, Grundy PE, Ritchey ML, Beckwith JB, Thomas PRM,
D'Angio GJ. Wilms' Tumor. In: Pizzo PA, Poplack DG (editors). Principles and Practice of
Pediatric Oncology (3rd Edition). Philadelphia: Lippincott-Raven Publishers, 733-759, 1997.
17.
Petruzzi MJ, Green DM. Wilms Tumor. In: Stockman JA III, Lohr JA (editors). Essence of Office
Pediatrics. Philadelphia. W.B. Saunders Company, 454, 2000.
18.
Petruzzi MJ, Green DM. Adult Wilms Tumor. In: Raghavan D, Brecher M, Johnson D, Meropol N,
Thigpen JT (editors). Textbook of Uncommon Cancer. Second Edition. Wiley-Liss, 21-27, 1999.
19.
Green DM, D’Angio GJ. Second Malignant Neoplasms. In: Abeloff MD, Armitage JO, Lichter AS,
Niederhuber JE (editors). Clinical Oncology, second edition. New York: Churchill Livingstone,
1082-1100, 2000.
20.
Green DM. Wilms Tumor. In: Glick PL, Pearl RH, Irish MS, Caty MG (editors). Pediatric Surgical
Secrets. Hanley and Belfus, Inc., 265-267, 2000.
21.
Green DM. Wilms Tumor. In: Rudolph AM, Rudolph CD, Siegel NJ, Lister G, Hostetter MK
(editors). Rudolph’s Pediatrics (21st Edition). McGraw – Hill, 1614 -1616, 2002.
GREEN - 23
22.
Grundy PE, Green DM, Breslow NE, Ritchey ML, Thomas PRM. Renal Tumors of Children. In:
Bast RC Jr, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E III (editors). Holland
Frei Cancer Medicine (e. 5). Hamilton: B.C. Decker, Inc. Publisher, 2174-2179, 2000.
23.
Green DM. Late Effects of Treatment of Cancer in Children and Adolescents. In: Bast RC Jr,
Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E III (editors). Holland Frei Cancer
Medicine (e. 5). Hamilton: B.C. Decker, Inc. Publisher, 2133-2139, 2000.
24.
Andersen BL, Green DM. Fertility and Sexuality after Cancer Treatment. In: Lenhard RE Jr,
Osteen RT, Gansler T (editors). The American Cancer Society’s Clinical Oncology. American
Cancer Society, Atlanta, 853-871, 2001.
25.
Grundy PE, Green DM, Coppes MJ, Breslow NE, Ritchey ML, Perlman EJ, Macklis RM. Renal
Tumors. In: Pizzo PA, Poplack DG (editors). Principles and Practice of Pediatric Oncology. Fourth
Edition. Lippincott Williams and Wilkins, Philadelphia, 865-893, 2002.
26.
Green DM. Wilms tumour - Commentary. In: Pinkerton R, Philip T, Fervers B (editors). Evidencebased Paediatric Oncology. BMJ Books, London, 72-73, 2002.
27.
Green DM. Late Effects of Treatment of Cancer in Children and Adolescents. In: Kufe DW,
Pollock RE, Weichselbaum RR, Bast RC Jr, Gansler TS, Holland JF, Frei E III (editors). Holland
Frei Cancer Medicine (e. 6). Hamilton: B.C. Decker, Inc. Publisher, 2299-2306, 2003.
28.
Green DM, D’Angio GJ. Second Malignant Neoplasms. In: Abeloff MD, Armitage JO,
Niederhuber JE, Kastan MB, McKenna WG (editors). Clinical Oncology, third edition. New York:
Churchill Livingstone, 1297-1316, 2004.
29.
Wallace H, Green D (editors). Late Effects of Childhood Cancer. Arnold, London, 1-416, 2004.
30.
Green DM. Pregnancy Outcome. In: Wallace H, Green D (editors). Late Effects of Childhood
Cancer. Arnold. London, 257-266, 2004.
31.
Plastaras, JP, Green DM, D’Angio GJ. Second Malignant Neoplasms. In: Abeloff MD, Armitage
JO, Niederhuber JE, Kastan MB, McKenna WG (editors). Clinical Oncology, fourth edition. New
York: Churchill Livingstone, 1023-1037, 2008.
Abstracts
1.
Green DM, Sallan S, Krishan A. Single-dose actinomycin D in relapsed childhood lymphocytic
leukemia. Proc Am Soc Clin Oncol; 18:302, 1977.
2.
Green DM. A phase I-II trial of pulse vincristine, actinomycin D and cyclophosphamide. Proc Am
Soc Clin Oncol; 19:324, 1978.
3.
Hardy B, Green DM. Folkman J. Radical prostatectomy in an 18-month old boy. Am Pediatric
Surg Assoc, 1978.
4.
Green DM, Brecher ML, Lindsay AN, Yakar D, Voorhess ML, MacGillivray MH, Freeman AI.
Thyroid function in pediatric patients after neck irradiation for Hodgkin's disease. Proc Am Assoc
Cancer Res; 21:130, 1980.
5.
Green DM, Fine WE, Li FP. Offspring of long-term survivors of unilateral Wilms' tumor. Proc Am
Soc Clin Oncol 1980; 21:390. Presented: San Diego, California, May 1980.
GREEN - 24
6.
Green DM, Sather HN, Sallan SE, Nesbit ME Jr, Freeman AI, Cassady JR, Sinks LF, Hammond
D, Frei E III. A comparison of three methods of central nervous system prophylaxis in childhood
acute lymphoblastic leukemia. Int Soc Pediatr Oncol (SIOP). Presented: Budapest, Hungary,
September 1980.
7.
Green DM, Brecher ML, Freeman AI. The use of intermediate dose methotrexate in childhood
acute lymphoblastic leukemia: A comparison of three versus six courses. Proc Am Assoc Cancer
Res 1981; 22:169. Presented: Washington, DC, April 1981.
8.
Grossi M, Green DM. Staphylococcus aureus bacteremia (SAB) in children and adolescents with
acute lymphoblastic leukemia. Proc Am Soc Clin Oncol; 22:409, 1981.
9.
Brecher ML, Gardner RV, Ettinger LJ, Green DM, Freeman AI. Intensive chemotherapy for
treatment of advanced Burkitt's lymphoma. Proc Am Soc Clin Oncol; 22:406, 1981.
10.
Meadows AT, Li FP, Jenkin RDT, Strong LC, Lemerle J, Green DM, Morris-Jones P, Newton WA.
Leukemia and lymphoma as a second malignant neoplasm (SMN) in children. Proc Am Soc Clin
Oncol 1981; 22:239. Presented: Washington, DC, May 1981.
11.
Green DM, Ghoorah J, Douglass HO Jr, Allen JE, Berjian RA, Jewett TC, Brecher ML,
Henderson ES, Freeman AI. The results of staging laparotomy in pediatric patients with
Hodgkin's disease. Clin Res 1981; 29:684A. Presented: Boston, Massachusetts, October 1981.
12.
Grossi M, Kowalczyk J, Suh O, Minowada J, Brecher ML, Green DM, Freeman AI, Sandberg AA.
Chromosomes as a prognostic factor (PF) in children and adolescents with acute lymphoblastic
leukemia (ALL). Proc Am Soc Clin Oncol 1982; 1:136. Presented: St. Louis, Missouri, April
1982.
13.
Green DM. The relationship between the absolute neutrophil count (ANC) and the occurrence of
bacteremia in febrile children and adolescents with acute lymphoblastic leukemia (ALL) at
diagnosis and during remission induction. Clin Res; 30:417A, 1982.
14.
Green DM. The relationship between the absolute neutrophil count (ANC) and the occurrence of
bacteremia in febrile children and adolescents with acute lymphoblastic leukemia (ALL) during
bone marrow relapse. Clin Res; 30:417A, 1982.
15.
Green DM, Brecher ML, Grossi M, Wang JJ, Sinks LF, Freeman AI. Intermediate dose
methotrexate (IDM) for childhood acute lymphoblastic leukemia (ALL). Proc Am Assoc Cancer
Res 1982; 23:123. Presented: St. Louis, Missouri, April 1982.
16.
Green DM, Yakar D, Brecher ML, Lindsay AN, MacGillivray MH, Voorhess ML. Ovarian function
in adolescent women following successful treatment for non-Hodgkin's lymphoma. Proc Am Soc
Clin Oncol 1982; 1:186. Presented: St. Louis, Missouri, April 1982.
17.
Green DM, Brecher ML, Grossi M, Simpson L, Fisher J, Allen JE, Cooney DR, Jewett TC,
Freeman AI. The treatment of yolk sac tumor with rotational combination chemotherapy. Am Acad
Pediatr (Section on Oncology/Hematology). Presented: New York, New York, October 1982.
18.
Green DM, Yakar D, Voorhess ML, Brecher ML, MacGillivray MH. Evaluation of patients with
post-irradiation thyroid dysfunction.
Clin Res; 30:701A, 1982.
Presented:
Boston,
Massachusetts, October 1982.
19.
Green DM, Blumenson LE, Brecher ML, Grossi M, Freeman AI. Do pneumococcal vaccine (PV)
and prophylactic antibiotics (PA) prevent pneumococcal bacteremia (PB) in splenectomized
pediatric patients with Hodgkin's disease? Proc Am Assoc Cancer Res; 24:158, 1983.
GREEN - 25
20.
Hall BH, Green DM. Sexual and reproductive function following treatment during childhood and
adolescence for cancer. Proc Am Soc Clin Oncol; 2:70, 1983.
21.
Grier H, Green DM, Cassady J, Delorey M, Goorin A, Belli J, Jaffe N, Gelber R, Price K,
Weinstein H. 10 years of vincristine (V), actinomycin D (A) and cyclophosphamide (C)
chemotherapy by intermittent (I) or bolus (B) route for Ewing's sarcoma. Proc Am Soc Clin Oncol;
2:74, 1983.
22.
Hall BH, Green DM. Sexual and reproductive function among men following treatment during
childhood and adolescence for cancer. Clin Res; 31:695A, 1983. Presented: Boston,
Massachusetts, October 1983.
23.
Green DM, Yan JC, Sallan S, Cassady JR, Danahy J, Fine W, Li FP. Second neoplasms after
Wilms' tumor in childhood. Int Soc Pediatr Oncol (SIOP). Presented: York, England, September
1983.
24.
Green DM, Brecher ML, Freeman A. Invasive infection due to hemophilus influenza - A late
complication of staging laparotomy for Hodgkin's disease. Proc Am Soc Clin Oncol; 3:234, 1984.
25.
Green DM, Brecher ML, Simpson L, Fisher J, Allen JE, Cooney DR, Jewett TC, Tebbi CK,
Freeman AI. The treatment of yolk sac tumor with bleomycin (B), vincristine (V) and cis-platinum
(P) followed by V, actinomycin D (A) and cyclophosphamide (C). Proc Am Assoc Cancer Res;
25:170, 1984.
26.
Schwenn M, Cassady JR, Delorey M, Price K, Green DM, Weinstein H. Patterns of failure
following combined modality therapy (CMT) for rhabdomyosarcoma (RMS). Proc Am Soc Clin
Oncol; 3:81, 1984.
27.
Fernbach D, Pick T, Green DM, Norkool P. The role of computerized tomography in the clinical
staging of Wilms' tumor. A report from the National Wilms' Tumor Study Group. Proc Int Soc
Pediatr Oncol (SIOP); 16:22, 1984.
28.
Green DM, Rosenberg HS, Cangir A, Brecher ML, Simpson L, Fisher J, Allen JE, Cooney DR,
Jewett TC, Tebbi CK, Freeman AI. Fatal pulmonary fibrosis in an infant treated with a
combination chemotherapy regimen containing bleomycin for presacral yolk sac tumor. Proc Am
Assoc Cancer Res; 26:185, 1985.
29.
Green DM, Gingell R, Pearce J, Panahon A, Ghoorah J. Evaluation of cardiac function in patients
(pts) treated with mediastinal irradiation (XRT) during childhood and adolescence for Hodgkin's
disease. Proc Am Soc Clin Oncol; 4:210, 1985.
30.
Green DM, Voorhess ML, Panahon A, Pearce J, MacGillivray M, Brecher ML. The relationship
between peak serum TSH level and recovery from post-irradiation thyroid hypofunction. Proc Int
Soc Pediatr Oncol (SIOP); 17:193, 1985. Presented: Venice, Italy, October 1985.
31.
Green DM. Childhood cancer in siblings. Proc Am Soc Clin Oncol; 5:214, 1986.
32.
Li FP, Gimbrere K, Gelber R, Flamant F, Green DM, Heyn R, Meadows A, Sallan S. Pregnancy
complications after radiotherapy for childhood Wilms' tumor. Proc Am Soc Clin Oncol; 5:202,
1986. Presented: Los Angeles, California, May 1986.
33.
Green DM. The availability of health insurance to long-term survivors of childhood cancer. Proc
Am Assoc Cancer Res; 27:200, 1986.
34.
Green DM. Pregnancy outcome following treatment during childhood and adolescence for
Hodgkin's disease. Blood; 68:210A, 1986. Presented: San Francisco, California, December
1986.
GREEN - 26
35.
Green DM, Brecher ML, Douglass HO Jr, Mindell ER, Ettinger LJ, Tebbi CK. The treatment of
pediatric patients with osteosarcoma of an extremity - Does pre-operative intra-arterial
chemotherapy affect prognosis. Proc Am Assoc Cancer Res; 28:219, 1987. Presented in
Atlanta, Georgia, May 1987.
36.
Green DM. Pregnancy outcome following treatment during childhood and adolescence for
Hodgkin's disease. Presented: Proc International Conference on Reproduction and Human
Cancer, Washington, DC, May 1987.
37.
Meadows AT, Obringer AC, Marrero O, Lemerle J, Fossati-Bellani F, Li F, Voute PA, Green DM,
Morris-Jones P, Greenberg M, Baum E, Nesbit M, Newton W, Siegel S. Risk of second malignant
neoplasms (SMN) in childhood Hodgkin's disease (HD): A report from the Late Effects Study
Group. Med Pediatr Oncol; 15:326, 1987. Presented: Jerusalem, Israel, September 1987.
38.
Green DM, Gaeta J, Pearce J, Panahon A, Henderson ES. Second malignant tumors (SMT)
following treatment during childhood and adolescence with orthovoltage (XRT) or megavoltage
(MXRT) irradiation with or without chemotherapy (chemo). Blood; 70:215A, 1987.
39.
Massina A, Piver CJ, Brecher ML, Freeman A, Green DM, Zevon MA. Adjustment to childhood
cancer: Sibling, patient and parental perspectives. Presented: Annual Meeting of the Society of
Behavioral Medicine, Boston, Massachusetts, March 1988.
40.
Massaro A, Green DM, Gaeta J, Pearce A, Panahon A, Henderson E. Second malignant tumors
(SMT) following treatment during childhood or adolescence for Hodgkin's disease. Proc Am Soc
Clin Oncol; 7:234, 1988.
41.
Grossi M, Maipang M, Brecher M, Green DM, Tebbi C, Freeman A. Use of VP-16 and
cyclophosphamide (CPM) in the treatment of acute monoblastic leukemia (AMOL) in children.
Proc Am Soc Clin Oncol; 7:185, 1988.
42.
Heary M, Brecher M, Zevon M, Green DM, Neubauer N. Relationship between illness impact,
information, and satisfaction with medical treatment in pediatric outpatients. Proc Am Soc Clin
Oncol; 7:268, 1988. Presented: New Orleans, Louisiana, May 1988.
43.
Green DM, Finklestein J, Tefft M, Norkool P. The occurrence of pneumocystis carinii pneumonia
after pulmonary irradiation for metastatic Wilms' tumor (A report from the National Wilms' Tumor
Study). Proc Am Soc Clin Oncol; 7:258, 1988.
44.
Zevon M, Neubauer NA, Green DM. Job satisfaction and stress reaction of patients treated
during childhood or adolescence for acute lymphoblastic leukemia (ALL). Proc Am Assoc Cancer
Res; 29:225, 1988. Presented: New Orleans, Louisiana, May 1988.
45.
Zevon M, Neubauer NA, Norman S, Green DM. Job satisfaction and defensive behavior in longterm survivors of Hodgkin's disease treated during childhood or adolescence. Med Pediatr Oncol;
16:440, 1988. Presented: Trondheim, Norway, August 1988.
46.
Green DM, Hall B. Growth and testicular function following treatment of Hodgkin's disease in
prepubertal patients with supradiaphragmatic irradiation and combination chemotherapy. Med
Pediatr Oncol; 16:442, 1988.
47.
Zevon MA, Heary MR, Brecher ML, Green DM, Neubauer NA. Parenting and childhood cancer:
Child characteristics as stressors. Presented: Annual Scientific Meeting of the Society of
Behavioral Medicine, San Francisco, California, May 1989.
48.
Green DM, Hall B, Zevon MA. Pregnancy outcome following treatment for acute lymphoblastic
leukemia (ALL) during childhood or adolescence. Proc Am Assoc Cancer Res; 30:278, 1989.
GREEN - 27
Presented: San Francisco, California, May 1989.
49.
Green DM, Ii Y, Grundy P, Breslow N, D'Angio GJ. The role of surgical excision in the
management of patients with pulmonary metastases from Wilms' tumor. Med Pediatr Oncol;
17:319, 1989. Presented: Prague, Czechoslovakia, September 1989.
50.
Green DM, Siegelstein N, Hall B, Zevon M. Pregnancy outcome following treatment for nonHodgkin's lymphoma (NHL) during childhood or adolescence. Blood; 74:375A, 1989.
51.
Green DM, Zevon M, Neubauer N. Employment, health and life insurance and marriage following
treatment for cancer in childhood or adolescence. Proc Am Soc Clin Oncol; 9:302, 1990.
Presented: Washington, DC, May 1990.
52.
Garber JE, Lynch EA, Meadows AT, Green DM, Tarbell NJ, Li FP. Pregnancy outcome after
therapy of childhood cancer. Proc Am Soc Clin Oncol; 9:290, 1990. Presented: Washington, DC,
May 1990.
53.
Green DM, Siegelstein N, Hall B, Zevon M. Congenital anomalies in the offspring of male patients
treated with chemotherapy for childhood cancer. Pediatr Res; 27:142A, 1990.
54.
Green DM, Siegelstein N, Hall B, Zevon M. Congenital anomalies in the offspring of female
patients treated with chemotherapy for childhood cancer. Pediatr Res; 27:142A, 1990.
55.
Zevon MA, Green DM, Lowrie G. Reproductive concerns among long-term survivors of child and
adolescent cancer. Am Psychol Assoc (submitted).
56.
Green DM, Zevon M, Neubauer N. Employment, health and life insurance and marriage following
treatment for cancer in childhood or adolescence. Med Pediatr Oncol; 18:413, 1990. Presented:
Rome, Italy, October 1990.
57.
Green DM, Michalek A, Prasad S, Zevon M. The long-term survival of those who survive for five
years after diagnosis of cancer during childhood or adolescence. Med Pediatr Oncol; 18:413,
1990. Presented: Rome, Italy, October 1990.
58.
Kakati S, Sreekantaiah C, Allen JE, Green DM, Fisher JE. An extrachromosomal element in a
family with Wilms' tumor. J Cancer Res Clin Oncol; 116(Suppl 1, Part 1):S169, 1990. Presented:
Hamburg, Germany, August 1990.
59.
Kakati S, Xiao H, Siddiqui S, Sreekantaiah C, Green DM, Fisher JE, Allen JE. Constitutional
extra chromosomal element with dispersed centromeric DNA in a family with Wilms' tumor. Am J
Hum Genet ; 47:A10, 1990. Presented: Cincinnati, Ohio, October 1990.
60.
Kakati S, Xiao H, Weier H, Green DM. Absence of chromosome 11 specific centromeric DNA in a
constitutional ring chromosome with dispersed centromeric DNA in a family with Wilms' tumor.
Proc Fourth International Workshop on Solid Tumors.
61.
Zevon MA, Lowrie GS, Green DM. Beliefs regarding the reproductive impact of cancer in
childhood and adolescence. Soc Behav Med. Presented: Washington, DC, March 1991.
62.
Green DM, Zevon MA, Lowrie G, Siegelstein N, Hall B. Pregnancy outcome following treatment
with chemotherapy for cancer in childhood and adolescence. Proc Am Assoc Cancer Res;
32:198, 1991. Presented: Houston, TX, May 1991.
63.
Green DM, Fernbach D, Norkool P, Kollia G, D'Angio G. The treatment of Wilms' tumor patients
with pulmonary metastases detected only with computerized tomography. A report from the
National Wilms' Tumor Study. Proc Am Soc Clin Oncol; 10:309, 1991. Presented: Houston, TX,
May 1991.
GREEN - 28
64.
Zevon MA, Corn B, Lowrie G, Green DM. Developmental status and intimacy in adult survivors of
childhood cancer. Am Psychol Assoc ERIC Document Reproduction Service No. ED 414547.
Presented: San Francisco, CA, August 1991.
65.
Green DM, Zevon MA, Lowrie G. Preliminary evaluation of a measure of reproductive concerns
(MRC) in long-term survivors of childhood cancer. Pediatr Res; 29:141A, 1991.
66.
Green DM, Zevon MA, Lowrie G, Michalak A. Factors affecting the long-term survival of five-year
survivors of childhood cancer. Pediatr Res; 29: 141A, 1991. Presented: New Orleans, LA, April
1991.
67.
Green DM, Zevon MA, Lowrie G, Siegelstein N, Hall B. Pregnancy outcome following treatment
with chemotherapy for cancer in childhood and adolescence. Med Pediatr Oncol; 19:428, 1991.
Presented: Rhodes, Greece, October 1991.
68.
Green DM, Zevon MA, Reese PA, Lowrie G. Second malignant tumors following treatment for
cancer in childhood and adolescence. Med Pediatr Oncol; 19:347-348, 1991. Presented:
Rhodes, Greece, October 1991.
69.
Petruzzi MJ, Green DM, Zevon MA, Lowrie JS. Development of second malignant tumors (SMT)
following treatment for Hodgkin's disease in childhood. Blood; 78:126a, 1991. Presented:
Denver, Colorado, December 1991.
70.
Green DM, Zevon MA, Reese PA, Lowrie G, Michalek AM, Gaeta J. Prior nitrosourea therapy is
associated with the occurrence of second malignant brain tumors. Proc Am Assoc Cancer Res;
33:209, 1991. Presented: San Diego, California, May 1992.
71.
Van Hoff J, Grier H, Douglass E, Green D. Etoposide, ifosfamide and cisplatin (VIP) therapy in
refractory childhood solid tumors: Response and toxicity. Proc Am Soc Clin Oncol; 11:368, 1992.
Presented in San Diego, California, May 1992.
72.
Maurer HM, Cantor A, Salzberg A, Pratt C, Thomas P, Parham D, Webber B, Marcus, R, Pick T,
Green D, Link M, Vietti T. Adjuvant chemotherapy vs. observation for localized nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) in children. Proc Am Soc Clin Oncol; 11:393,
1992. Presented: San Diego, California, May 1992.
73.
Green D, Breslow N, Kao P, Finklestein J, Evans A, D'Angio G. A comparison of the
hematological toxicity of standard and pulse-intensive regimens for the treatment of Wilms' tumor.
A report from the National Wilms' Tumor Study. Proc Am Soc Clin Oncol; 11:376, 1992.
74.
Stephens EA, Lowrie GS, Zevon MA, Reese PA, Michalek AM, Gaeta J, Green DM. Second
malignant tumors following treatment for cancer in childhood and adolescence. Pediatr Res;
31:145A, 1992.
75.
Green DM, Breslow NE, Kao P-T, Finklestein JZ, Evans AE, D'Angio GJ. A comparison of the
hematological toxicity of standard and pulse-intensive regimens for the treatment of Wilms' tumor.
Med Pediatr Oncol; 20:433, 1992. Presented: Hanover, Germany, October 1992.
76.
Green DM, Breslow NE, Kao P-T, Takashima J, D'Angio GJ. The treatment of patients with stage
I/favorable histology Wilms' tumor. Med Pediatr Oncol; 20:435, 1992. Presented: Hanover,
Germany, October 1992.
77.
Maurer HM, Cantor A, Salzberg A, Pratt C, Thomas P, Parham D, Webber B, Marcus, R, Pick T,
Green D, Link M, Vietti T. Adjuvant chemotherapy vs. observation for localized nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) in children. Med Pediatr Oncol; 20:388, 1992.
Presented: Hanover, Germany, October 1992.
GREEN - 29
78.
Mertens A, Robison L, Dreyer Z, Green D, Sklar C, Neglia. Childhood cancer survivor study: A
pilot study. Soc Pediatr Epidemiol Res (submitted).
79.
Green DM, Zevon MA, Lowrie GS. Further survival of five year survivors of childhood cancer.
Proc Am Assoc Cancer Res; 34:197, 1993. Presented: Orlando, FL, May 1993.
80.
Green D, Zevon M, Lowrie J, Michalek A, Reese P. Second malignant tumors (SMTs) after
treatment for childhood cancer: Significance of splenectomy and prior treatment with doxorubicin.
Proc Am Soc Clin; Oncol; 12:173, 1993.
81.
Green DM, Zevon MA, Lowrie GS. Further survival of five year survivors of childhood cancer.
Pediatr Res; 33:139A, 1993.
82.
Green DM, Zevon MA, Lowrie GS, Michalek AM, Reese PA. Second malignant tumors (SMTs)
after treatment for childhood cancer: Significance of splenectomy and prior treatment with
doxorubicin. Pediatr Res; 33:139A, 1993. Presented: Washington, DC, May 1993.
83.
Green DM, Breslow NE, Evans I, Moksness J, Finklestein JZ, D'Angio GJ. Effect of dose
schedule on hematological toxicity and dose intensity of combination chemotherapy with
vincristine (VCR) and actinomycin D (ACTD) for the treatment of stage I and II Wilms tumor. A
report from the National Wilms Tumor Study. Med Pediatr Oncol; 21:601, 1993. Presented: San
Francisco, CA, October 1993.
84.
Green DM, Breslow NE, Evans I, Moksness J, Finklestein JZ, D'Angio GJ. Effect of dose
schedule on hematological toxicity and dose intensity of combination chemotherapy with
vincristine (VCR), actinomycin D (ACTD) and Adriamycin (ADR) for the treatment of Wilms tumor.
A report from the National Wilms Tumor Study. Med Pediatr Oncol; 21:602, 1993. Presented:
San Francisco, CA, October 1993.
85.
Zevon MA, Lowrie GS, Corn B, Green D. Adult childhood cancer survivors: Developmental
impact of age at diagnosis. Presented: American Psychological Association.
86.
Schwabe K, Zevon MA, Shaver P, Green DM. Dissociation in adult survivors of childhood cancer.
American Psychological Association (submitted).
87.
Green DM, Moksness J, Breslow NE, Beckwith JB, D'Angio GJ. The treatment of children with
clear cell sarcoma of the kidney (CCSK). A report from the National Wilms Tumor Study (NWTS).
Proc Am Assoc Cancer Res; 35:239, 1994. Presented: San Francisco, CA, April 1994.
88.
Green D, Beckwith J, Breslow N, Faria P, Moksness J, Finklestein J, Grundy P, Thomas P, Kim
T, Shochat S, Haase G, Ritchey M, Kelalis P, D'Angio G. The treatment of children with focal or
diffuse, anaplastic Wilms tumor. A report from the National Wilms Tumor Study (NWTS). Proc Am
Soc Clin Oncol; 13:413, 1994. Presented: Dallas, TX, May 1994.
89.
Diller L, Dreyfus MG, Breslow N, Green DM, Li FP, Pelletier J. Constitutional mutations of the
WT1 gene in patients with Wilms tumor (WT) and genitourinary (GU) anomalies. Proc Am Soc
Clin Oncol; 13:422, 1994. Presented: Dallas, TX, May 1994.
90.
Green DM, Zevon MA, Lowrie G. Survival of five year survivors of childhood cancer. Pediatr Res;
35:161A, 1994. Presented in Seattle, WA, May 1994.
91.
Green DM, Breslow NE, Moksness J, D'Angio GJ. Congestive heart failure following initial
therapy for Wilms tumor. A report from the National Wilms Tumor Study. Pediatr Res; 35:161A,
1994. Presented: Seattle, WA, May 1994.
92.
Ritchey ML, Green DM, Breslow N, Moksness J, Norkool P. Accuracy of current imaging
GREEN - 30
modalities in the diagnosis of synchronous bilateral Wilms tumor: A report from the National
Wilms Tumor Study Group. J Urol; 151:329A, 1994. Presented: San Francisco, CA, May 1994.
93.
Ritchey ML, Green DM, Thomas P, Haase G, Shochat S. Renal failure in Wilms tumor. Med
Pediatr Oncol; 23:264, 1994. Presented: Paris, France, September 1994.
94.
Green DM, Zevon MA, Lowrie G, Michalek AM. Survival of five year survivors of childhood
cancer. Med Pediatr Oncol; 23:237, 1994. Presented: Paris, France, September 1994.
95.
Green DM, Zevon MA, Lowrie G, Michalek AM, Reese PA. Second malignant tumors after
treatment for childhood cancer. Med Pediatr Oncol; 23:238, 1994. Presented: Paris, France,
September 1994.
96.
Green DM, Zevon MA, Lowrie G, Michalek AM. Further survival and cause of death of five year
survivors of childhood cancer. Proc Am Assoc Cancer Res; 36:232, 1995. Presented: Toronto,
Canada, March 1995.
97.
Green D, Zevon M, Lowrie G. Doxorubicin is a significant risk factor for second malignant tumors
(SMTs) after treatment for childhood cancer. Proc Am Soc Clin Oncol; 14:438, 1995. Presented:
Los Angeles, CA, May 1995.
98.
Green DM, Fiorello A, Zevon MA, Lowrie GS. Pregnancy outcome following treatment with
chemotherapy for cancer during childhood or adolescence. Pediatr Res; 37:157A, 1995.
Presented: San Diego, CA, May 1995.
99.
Breslow NE, Takashima JR, Whitton JA, Moksness J, D'Angio GJ, Green DM. Second malignant
neoplasms (SMN) following treatment for Wilms tumor. A report from the National Wilms Tumor
Study Group. Pediatr Res; 37:156A, 1995. Presented: San Diego, CA, May 1995.
100.
Green D, Fiorello A, Zevon M, Hall B, Lowrie G, Seigelstein N. Birth defects and childhood
cancer in offspring of survivors of childhood cancer. Proc Am Assoc Cancer Res; 37:256, 1996.
Presented: Washington, DC, April 1996.
101.
Green D, Breslow N, Beckwith J, Finklestein J, Grundy P, Thomas P, Kim T, Shochat S, Haase
G, Ritchey M, Kelalis P, D'Angio G. A comparison between single dose and divided dose
administration of dactinomycin and doxorubicin. A report from the National Wilms Tumor Study
Group. Proc Am Soc Clin Oncol; 15:457, 1996. Presented: Philadelphia, PA, May 1996.
102.
Tomlinson GE, Breslow NE, Moksness J, Beckwith JB, D'Angio GJ, Green DM. Prognostic
factors in rhabdoid tumor of the kidney: Results of the National Wilms Tumor Study Group
(NWTSG). Proc Am Soc Clin Oncol; 15:460, 1996. Presented: Philadelphia, PA, May 1996.
103.
Green D, Breslow N, Beckwith J, Finklestein J, Grundy P, Thomas P, Kim T, Shochat S, Haase
G, Ritchey M, Kelalis P, D'Angio G. A comparison between single dose and divided dose
administration of dactinomycin and doxorubicin. A report from the National Wilms Tumor Study
Group. Med Pediatr Oncol; 27:218, 1996. Presented: Vienna, Austria, October 1996.
104.
D'Angio GJ, Breslow N, Mahboubi S, Takashima JR, Green DM. Chondrosarcomas (CHSAs) can
develop in post-irradiation osteochondromas (OSCHs). Med Pediatr Oncol; 27:216, 1996.
Presented: Vienna, Austria, October 1996.
105.
Green DM. Long-term complications of bone marrow transplantation. J Paediatr Child Health;
33:S32, 1996. Presented: Hong Kong, March 1997.
106.
Green DM, Breslow N, Beckwith J, Finklestein J, Grundy P, Thomas P, Kim T, Shochat S, Haase
G, Ritchey M, Kelalis P, D'Angio G. A comparison between short and long courses of therapy for
Wilms tumor. A report from the National Wilms Tumor Study Group. Proc Am Assoc Cancer Res;
GREEN - 31
38:527, 1997. Presented: San Diego, CA, April 1997.
107.
Green DM, Zevon MA, Hall B. Cigarette smoking among survivors of cancer diagnosed during
childhood or adolescence. Proc Am Soc Clin Oncol; 16:519A, 1997. Presented: Denver, CO,
May 1997.
108.
Green DM, Breslow N, Beckwith J, Finklestein J, Grundy P, Thomas P, Kim T, Shochat S, Haase
G, Ritchey M, Kelalis P, D'Angio G. A comparison between short and long courses of therapy for
Wilms tumor. A report from the National Wilms Tumor Study Group. Med Pediatr Oncol; 29:370,
1997. Presented: Istanbul, Turkey, September 1997.
109.
Meisel JA, Guthrie KA, Breslow NE, Green DM, Donaldson SS. Significance and management of
computed tomography-detected pulmonary metastases in Wilms’ tumor: A report from the Third
and Fourth National Wilms’ Tumor Studies. Int J Rad Oncol Biol Phys; 39(Suppl):143, 1997.
Presented: Orlando FL, October 1997.
110.
Green DM, Lee MJ, Barcos M, Hall B, Zevon MA. Second malignant neoplasms (SMNs) after
treatment for Hodgkin disease in childhood or adolescence. Proc Am Assoc Cancer Res; 39:504,
1998. Presented: New Orleans LA, April 1998.
111.
Amar AM, Tomlinson G, Green DM, Breslow NE, deAlarcon PA. The clinical presentation of
rhabdoid tumors of the kidney. Pediatr Res; 43:130A, 1998. Presented: New Orleans, LA, May
1998.
112.
Green DM, Zevon MA. Further survival and cause of death of ten year survivors of childhood
cancer. Proc Am Soc Clin Oncol; 17:540A, 1998. Presented: Los Angeles CA, May, 1998.
113.
Green DM, Chung CS, Zevon MA, Hall BC. Excess cancer and cardiac mortality among ten-year
survivors of childhood cancer. Med Pediatr Oncol; 31:211, 1998. Presented: Yokohama, Japan,
October 1998.
114.
Perlman EJ, Shuster A, Argani P, Beckwith JB, Grundy P, D’Angio G, Green D. Genetic analysis
of clear cell sarcoma of kidney (CCSK) by comparative genomic hybridization (CGH). Soc Pediatr
Pathol (accepted).
115.
Argani P, Perlman EJ, Breslow N, Browning N, Green D, D’Angio G, Beckwith JB. Clear cell
sarcoma of kidney (CCSK): A study of 185 cases treated on NWTS 1 - 4. Soc Pediatr Pathol
(accepted).
116.
Coppes MJ, Arnold M, Beckwith JB, Ritchey ML, D’Angio GJ, Green DM, Breslow NE. Risk
factors for metachronous bilateral Wilms tumor. Pediatr Res; 45:145A, 1999. Presented: San
Francisco, CA, May 1999.
117.
Green DM, Chung CS, Zevon MA, Hall BC. Excess mortality among fifteen-year survivors of
childhood cancer. Proc Am Assoc Cancer Res; 40:605, 1999. Presented: Philadelphia, PA, April
1999.
118.
Reynolds JA, Green DM, Barcos MP, Lee RJ, Hall BC, Zevon MA. Second malignant
neoplasms(SMNs) after treatment for Hodgkin disease in childhood or adolescence. Pediatr Res;
45:151A, 1999. Presented: San Francisco, CA, May 1999.
119.
Green DM, Barcos MP, Lee RJ, Reynolds JA, Hall BC, Zevon MA. Basal cell carcinoma after
treatment for Hodgkin disease in childhood or adolescence. Pediatr Res; 45:147A, 1999.
Presented: San Francisco, CA, May 1999.
120.
Green DM, Peabody E, Tait PP, Norkool PP, Breslow NE. Pregnancy outcome after treatment for
Wilms tumor. A report from the National Wilms Tumor Study Group (NWTSG). Proc Am Soc Clin
GREEN - 32
Oncol; 18:560A, 1999. Presented: Atlanta, GA, May 1999.
121.
Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, Greffe B, Wolden S, Robison L.
Thyroid dysfunction in survivors of Hodgkin’s disease: Data from the Childhood Cancer Survivor
Study (CCSS). Pediatr Res; 45:98A, 1999. Presented: San Francisco, CA, May 1999.
122.
Green DM, Whitton J, Stovall M, Mertens A, Ruymann F, Pendergrass T, Robison L. Pregnancy
outcome after treatment for cancer during childhood or adolescence. A report from the Childhood
Cancer Survivor Study (CCSS). Med Pediatr Oncol; 33:146, 1999. Presented: Montreal,
Quebec, Canada, September 1999.
123.
Green DM. Progress in the management of Wilms tumor. Jap Clin Oncol Soc J; 34:4, 1999.
Presented: Gifu, Japan, October 1999.
124.
Green DM, Zevon MA, Somov P, Piper BF, Hall BC. Fatigue after treatment for Hodgkin disease
during childhood or adolescence. Proc Am Assoc Cancer Res; 41:417, 2000. Presented: San
Francisco, CA, April 2000.
125.
Green DM, Breslow NE, Beckwith B, Ritchey ML, Shamberger RC, Haase GM, D’Angio GJ,
Donaldson MH, Grundy PE, Weetman RM, Coppes MJ, Malogolowkin MH, Shearer P, Coccia P,
Kletzel M, Thomas P, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D. Treatment with
nephrectomy only for small, stage I/favorable histology Wilms tumor. A report from the National
Wilms Tumor Study Group. Proc Am Soc Clin Oncol; 19:582A, 2000. Presented: New Orleans,
LA, May 2000.
126.
Tannous R, Giller R, Holmes E, Kim T, LaQuaglia M, Malogolowkin MM, Montebello J, Sposto R,
Green D, Coccia P. Intensive therapy for high risk (HR) relapsed Wilms’ tumor (WT): A CCG4921/POG-9945 study report. Proc Am Soc Clin Oncol; 19:558A, 2000. Presented: New
Orleans, LA, May 2000.
127.
Leonard GT, Green DM, Spangenthal EL, Gingell RL, Barcos MP, Lee RJ, Hall BC, Zevon MA.
Cardiac mortality and morbidity after treatment for Hodgkin disease during childhood or
adolescence. Pediatr Res; 47:46A, 2000. Presented: Boston, MA, May 2000.
128.
Green DM, Nan B, Grigoriev Y, Takashima J, Norkool P, D’Angio GJ, Breslow NE. Congestive
heart failure (CHF) after treatment for Wilms tumor. A report from the National Wilms Tumor
Study Group. Med Pediatr Oncol; 35:200, 2000. Presented: Amsterdam, The Netherlands,
October 2000.
129.
Tomlinson G, Breslow N, Savla J, Schneider N, D’Angio G, Green D. Rhabdoid tumor of the
kidney (RTK): Epidemiologic and molecular analyses. Med Pediatr Oncol; 35:237, 2000.
Presented: Amsterdam, The Netherlands, October 2000.
130.
Coppes MJ, Perlman, E, Tremblay C, D’Angio GJ, Green D, Egeler RM. Intracranial metatases
from Wilms tumor: A report from the National Wilms Tumor Study Group (NWTSG). Med Pediatr
Oncol; 35:267, 2000. Presented: Amsterdam, The Netherlands, October 2000.
131.
Green DM, Whitton J, Stovall M, Mertens A, Donaldson SS, Ruymann F, Pendergrass TW,
Robison L. Pregnancy outcome of partners of male survivors of childhood cancer. A report from
the Childhood Cancer Survivor Study. Proc Am Assoc Cancer Res; 42:741, 2001. Presented:
New Orleans, LA, March 2001.
132.
Rauck AM, Williamson J, Yasui Y, Green DM, Robison L. Treatment with surgery, irradiation, and
chemotherapy decreases marriage in survivors of CNS tumors: A report from the Childhood
Cancer Survivor Study. Proc Am Assoc Cancer Res; 42:742, 2001. Presented: New Orleans,
LA, March 2001.
GREEN - 33
133.
Green D, Peabody E, Norkool P, Nan B, Breslow N. Pregnancy outcome after treatment for
Wilms tumor. An update from the National Wilms Tumor Study Group. Proc Am Soc Clin Oncol;
20:377A, 2001. Presented: San Francisco, CA, May 2001.
134.
Green D, Zevon MA, Rock KM, Chavez F. Sleep quality in long-term survivors of Hodgkin
disease. Med Pediatr Oncol; 37:309, 2001. Presented: Brisbane, Australia, October 2001.
135.
Green DM, Zevon MA, Rock KM, Chavez F. Fatigue after treatment for Hodgkin’s disease during
childhood or adolescence. Proc Am Soc Clin Oncol; 21:396A, 2002. Presented: Orlando, FL,
May 2002.
136.
Blakely ML, Shamberger RC, Norkool P, Beckwith JB, D’Angio GJ, Green DM, Ritchey ML.
Outcome of children with cystic partially – differentiated nephroblastoma treated with or without
chemotherapy. Presented: American Acad Pediatr Surgical Section, October 2002.
137.
Mulrooney DA, Mertens AC, Neglia JP, Green DM, Zeltzer L, Robison LL. Fatigue and sleep
disturbance in survivors of childhood cancer: A Report from the Childhood Cancer Survivor Study
(CCSS). Proc Am Soc Clin Oncol; 22:761, 2003. Presented: Chicago, IL, June 2003.
138.
Seibel N, Li S, Breslow NE, Beckwith JB, Green DM, D’Angio GJ, Ritchey ML, Thomas PR,
Grundy PE, Finklestein JZ. Effect of duration of treatment on treatment outcome for patients with
clear cell sarcoma of the kidney (CCSK): A report from the National Wilms Tumor Study Group.
Proc Am Soc Clin Oncol; 22:800, 2003. Presented: Chicago, IL, June 2003.
139.
Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Mulder J, Green DM, Nicholson S, Yasui Y,
Robison LL. Premature menopause in survivors of childhood and adolescent cancer: Data from
the Childhood Cancer Survivor Study (CCSS). Pediatr Res; 55:297A, 2004. Presented: San
Francisco, CA, May 2004.
140.
Green DM. Late effects of treatment for childhood cancer. Bangl J Child Health; 27 (2)
(Supplement):S-15, 2004. Presented: Dhaka, Bangladesh, February, 2004.
141.
Feusner JH, Green D, Norkool P, Ritchey M. Chemotherapy dosing for Wilms tumor patients on
hemodialysis: Experience of the National Wilms Tumor Study. Proc Am Soc Clin Oncol; 23:809,
2004. Presented: New Orleans, LA, June 2004.
142.
Dome JS, Bockhold CA, Li SM, Green DM, Baker S, Perlman EJ, Hill DA, Breslow NE.
Telomerase RNA expression as a prognostic marker in patients with favorable histology Wilms
Tumor. Proc Am Soc Clin Oncol; 23:799, 2004. Presented: New Orleans, LA, June 2004.
143.
Mulrooney DA, Mertens AC, Neglia JP, Green DM, Zeltzer L, Robison LL. Fatigue and sleep in
survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). Proc
Am Soc Clin Oncol; 23:757, 2004. Presented: New Orleans, LA, June 2004.
144.
Green DM, Malogolowkin M, Cotton C, Breslow NE, Perlman E, Miser J, Beckwith JB, Ritchey
ML, Shamberger RC, Haase GM, D’Angio GJ, Donaldson M, Grundy PE, Weetman R, Coppes
MJ, Shearer P, Coccia P, Kletzel M, Thomas PRM, Macklis R, Tomlinson G, Huff V, Newbury R,
Weeks D. Treatment of Wilms tumor relapsing after initial treatment with vincristine and
actinomycin D. A report from the National Wilms Tumor Study (NWTS) Group. Proc Am Soc Clin
Oncol; 23:812S, 2005. Presented: Orlando, FL, May 14, 2005.
145.
Malogolowkin M, Green DM, Cotton C, Breslow NE, Perlman E, Miser J, Beckwith JB, Ritchey
ML, Shamberger RC, Haase GM, D’Angio GJ, Donaldson M, Grundy PE, Weetman R, Coppes
MJ, Shearer P, Coccia P, Kletzel M, Thomas PRM, Macklis R, Tomlinson G, Huff V, Newbury R,
Weeks D. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin
D and doxorubicin. A report from the National Wilms Tumor Study (NWTS) Group. Proc Am Soc
Clin Oncol; 23:801S, 2005. Presented: Orlando, FL, May 15, 2005.
GREEN - 34
146.
Dome JS, Green DM, Cotton C, Breslow NE, Perlman E, Miser J, Ritchey ML, Shamberger RC,
Thomas PRM, Grundy P, D’Angio GJ, Malogolowkin M, Haase GM, Beckwith JB, Donaldson M,
Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V,
Newbury R, Weeks D. Treatment of anaplastic Wilms tumor: A report from the National Wilms
Tumor Study Group. Proc Am Soc Clin Oncol; 23:802S, 2005. Presented: Orlando, FL , May 15,
2005.
147.
Kalapurakal JA, Anderson JR, Peterson S, Shamberger R, Ritchey M, Haase G, D’Angio GJ,
Thomas PRM, Green DM, Dome J, Grundy P. Treatment outcomes in children with favorable
histology Wilms tumor and peritoneal implants: A report from the National Wilms Tumor Study – 4
and – 5. Pediatr Blood Cancer; 45:389, 2005. Presented: Vancouver, British Columbia,
September 21, 2005.
148.
Shamberger R, Grundy P, Green D. Nephrectomy only for very low risk Wilms tumor (VLRWT).
Pediatr Blood Cancer; 45:377, 2005. Presented: Vancouver, British Columbia, September 24,
2005.
149.
Seibel NL, Sun J, Anderson JR, Breslow NE, Perlman EJ, Ritchey ML, Thomas PR, Coppes MJ,
Grundy PE, Green DM. Outcome of clear cell sarcoma of the kidney (CCSK) treated on the
National Wilms Tumor Study-5 (NWTS). Proc Am Soc Clin Oncol; 24:502S, 2006. Presented:
Atlanta, Georgia, June 3, 2006.
150.
Green DM, Kawashima T, Leisenring W, Stovall M, Donaldson S, Sklar CA, Byrne J, Robison LL.
Fecundity of females after treatment for childhood cancer. A preliminary report from the
Childhood Cancer Survivor Study (CCSS). Pediatr Blood Cancer; 47:385-386, 2006. Presented:
Geneva, Switzerland, September 20, 2006.
151.
Warwick AB, Kalapurakal JA, Ou S-S, Green DM, Norkool PA, Breslow NE. Portal hypertension
in patients with Wilms’ tumors. Pediatr Blood Cancer; 47:494, 2006. Presented: Geneva,
Switzerland, September 19, 2006.
152.
Fernandez CV, Anderson J, Breslow N, Dome J, Grundy P, Perlman E, Green D. Patient weight
and event free survival for children under 2 years of age at diagnosis with favorable histology
Wilm’s tumor. Proc Am Soc Clin Oncol; 25:722S, 2007.
153.
Green DM, Kawashima T, Leisenring W, Stovall M, Donaldson SS, Sklar CA, Byrne J, Robison
LL. Fecundity of males after treatment for childhood cancer. A report from the Childhood Cancer
Survivor Study (CCSS). Proc Am Soc Clin Oncol; 25:530S, 2007. Presented: Chicago, Illinois,
June 3, 2007.
154.
Green DM, Kawashima T, Leisenring W, Stovall M, Donaldson SS, Sklar CA, Byrne J, Robison
LL. Fertility of males after treatment for childhood cancer. A report from the Childhood Cancer
Survivor Study (CCSS). Pediatr Blood Cancer; 49:413, 2007. Presented: Mumbai, India
November 1, 2007.
155.
Mulvihill JJ, Munroe H, Whitton JA, Green DM, Mertens AC, Weathers R, Stovall M, Strong LC,
Robison LL, Boice JD and investigators of the Childhood Cancer Survivor Study: Genetic
disease in offspring of survivors with childhood and adolescent cancer. Presented: Am Soc
Human Genet, San Diego, California, October 26, 2007.
156.
Green DM, Kawashima T, Leisenring W, Stovall M, Donaldson SS, Sklar CA, Byrne J, Robison
LL. Fertility of females after treatment for childhood cancer. A report from the Childhood Cancer
Survivor Study (CCSS). Proc Am Soc Clin Oncol; 26:541S, 2008. Presented: Chicago, Illinois,
May 31, 2008.
157.
Mulrooney DA, Yeazel M, Mitby P, Kawashima T, Leisenring WM, Stovall M, Green DM, Sklar
GREEN - 35
CA, Robison LL, Mertens AC. Cardiovascular disease in adult survivors of childhood and
adolescent cancer: A report from the Childhood Cancer Survivor Study (CCSS). Proc Am Soc
Clin Oncol; 26;504S, 2008. Presented: Chicago, Illinois, May 31, 2008.
158.
Rokitka, DA, Va P, Green DM, Mahoney MC. Secondary malignant neoplasms among children
and adolescents following treatment for Hodgkin disease. Proc Am Soc Clin Oncol; 26:552S,
2008. Presented: Chicago, Illinois, June 1, 2008.
159.
Green DM, Lange J, Peterson S, Kalapurakal JA, Breslow NE. Pregnancy outcome after
treatment for Wilms tumor: A report from the National Wilms Tumor Study Group. Presented:
Proc Int Soc Paediatr Oncol; 67 (Abstract O.177), Berlin, Germany, October 5, 2008.
160.
Inaba H, Zhu L, Srivastava K, Hudson MM, Motosue MS, Stokes DC, McPherson Srinivasan S,
Krasin MJ, Green DM, Spunt SL. Pulmonary function after whole lung radiation in pediatric
patients with malignant solid tumors. Proc Am Soc Clin Oncol; 525S, 2009. Presented Orlando,
Florida, June 1, 2009.
161.
Ness KK, Hudson MM, Pui CH, Green DM, Karlage R, Robison LL, Morris EB. Signs and
symptoms of peripheral neuropathy in adult survivors of childhood acute lymphoblastic leukemia
(ALL): associations with physical performance and chemotherapy doses. Proc Am Soc Clin
Oncol; 28:643S, 2010. Presented Chicago, Illinois, June 8, 2010.
162.
Green DM, Nolan VG, Kawashima T, Stovall M, Donaldson SS, Sklar CA, Robison LL.
Hypothalamic/Pituitary radiation exposure in low doses may result in decreased fertility in female
Childhood Cancer Survivor Study (CCSS) participants. Proc Am Soc Clin Oncol; 28:688S, 2010.
Presented: Chicago, Illinois, June 6, 2010.
163.
Termuhlen AM, Tersak JM, Yasui Y, Liu Q, Stovall M, Deutsch M, Sklar CA, Oeffinger KC,
Robison LL, Green DM. Chronic medical conditions, health status, and health care practices at
25 years in 5-year survivors of Wilms tumor: A report from the Childhood Cancer Survivor Study.
Proc Am Soc Clin Oncol; 28:681S, 2010. Presented: Chicago, Illinois, June 7, 2010.
164.
Hudson MM, Nolan VG, Ness KK, Armstrong G, Green D, Krull K, Spunt S, Metzger M,
Srivastava DK, Robison LL. Yield from Risk-Based Screening in Adults Treated for Cancer in
Childhood. Proc Am Soc Clin Oncol; 28:638S, 2010. Presented: Chicago, Illinois, June 5, 2010.
165.
Green D, Zhu L, Joshi V, Ness K, Srivastava K, Armstrong G, Stokes D, Robison L, Hudson M.
Pulmonary hypertension after treatment for childhood cancer. A report from the St. Jude Lifetime
Cohort Study. Pediatr Blood Cancer; 55:825, 2010. Presented: Boston, Massachusetts, October
2010.
166.
Armstrong GT, Ness KK, Nolan VG, Green DM, Joshi V, Hudson M, Robison LL, Srivastava D,
Durand J-B Plana JC, MD. Myocardial strain for detection of treatment-related cardiac toxicity in
adult survivors of pediatric cancer. Pediatr Blood Cancer; 55:941, 2010. Presented: Boston,
Massachusetts, October 2010.
167.
Ehrlich P, Ou SS, Ritchey M, Green D, Dome J, Grundy P, Perlman E, Kalapurakal J,
Shamberger R, Breslow N. Clinico-pathologic findings predictive of relapse in children with stage
III favorable histology Wilms tumor: The importance of lymph nodes. Pediatr Blood Cancer;
55:793, 2010. Presented: Boston, Massachusetts, October 2010.
168.
Cox CL, Zhu L, Ness KK, Krull KR, Robison LL, Green DM. Obesity among Childhood Cancer
Survivor Study participants: New targets for intervention. Am Public Health Assoc, 2010.
Presented: Denver, Colorado, November 10, 2010.
169.
Kieran K, Dome JS, Ehrlich PF, Ritchey ML, Shamberger RC, Green DM, Davidoff AM. Lymph
node sampling in Wilms tumor : what is “enough ”? Presented: American Pediatric Surgical
GREEN - 36
Association, Palm Desert, California, May 23, 2011.
170.
Mullen EA, Anderson JR, Steacy KJ, Geller JI, Green DM, Norkool P, Fernandez CV, Khanna G,
Malogolowkin MH, Dome J. The impact of surveillance imaging on overall survival in patients
with recurrent Wilms tumor: A report from the Children’s Oncology Group. J Clin Oncol 29:593s,
2011. Presented: Chicago, Illinois, June 2011.
171.
Green DM, Nolan VG, Srivastava K, Leisenring W, Neglia JP, Sklar CA, Hudson MM, Diller L,
Stovall M, Robison LL. Quantifying alkylating agent exposure: Evaluation of the
cyclophosphamide equivalent dose. A report from the Childhood Cancer Survivor Study. J Clin
Oncol 29:596s. Presented: Chicago, Illinois, June 2011.
172.
Green DM, Nolan VG, Srivastava K, Leisenring W, Neglia JP, Sklar CA, Hudson MM, Diller L,
Stovall M, Robison LL. Use of inhibin B and follicle stimulating hormone (FSH) for identification of
male survivors of childhood cancer with azoospermia. A report from the St. Jude Lifetime Cohort
Study (SJLIFE). Pediatr Blood Cancer 57:714, 2011. Presented: Auckland, New Zealand,
October 2011.
173.
Ness K, Green DM, Gurney JG, Bass JK, Smith WA, Huang TT, Robison LL, Hudson MM.
Balance impairment in adult survivors of childhood cancer treated with platinum. Pediatr Blood
Cancer 57:709, 2011. Presented: Auckland, New Zealand, October 2011.
.
174.
Kieran K, Anderson JR, Dome JS, Ehrlich PF, Ritchey ML, Shamberger RC, Perlman EJ, Green
DM, Davidoff A. Is adrenalectomy necessary during unilateral nephrectomy for Wilms Tumor?
(accepted).
175.
Smith WA, Li C, Nottage K, Srivastava D, Lanctot J, Green DM, Nolan VG, Laver JH, Gurney J,
Robison LL, Hudson MM, Ness KK. Dietary intake and metabolic syndrome in adult survivors of
childhood cancer. J Clin Oncol. 30:612s, 2012. Presented: Chicago, Illinois, June 2012.
176.
Mulrooney D, Yeazel M, Kawashima T, Mertens A, Mitby P, Stovall M, Donaldson S, Green D,
Sklar C, Robison L, Leisenring W. Cardiovascular disease in adult survivors of childhood and
adolescent cancer: A Report from the Childhood Cancer Survivor Study (CCSS). ASA
Conference on Radiation and Health. June 2012.
177.
Denbo JW, Zhu L, Srivastava D, Stokes D, Srinivasan S, Hudson MM, Ness K, Robison LL, Neel
M, Rao B, Navid F, Davidoff AM , Green DM. Long-term pulmonary function after metastatectomy
for childhood osteosarcoma. Society for Surgical Oncology (accepted).
178.
Smith WA, Ness KK, Joshi VM, Robison LL, M. Hudson MM, Green DM. Exercise training in
childhood cancer survivors with subclinical cardiomyopathy. Experimental Biology 2013.
Presented: Boston, Massachusetts, April 2013.
179.
Green DM, Merchant TE, Billups C, Stokes DC, Broniscer A, Srinivasan A, Chintagumpala MM,
Hassall TE, Bouffet E, Gururangan S, Kellie SJ, Ashley DM, Cohn RJ, Fisher MJ, Gajjar.
Pulmonary function after treatment for embryonal brain tumors on SJMB03 that included
craniospinal irradiation. J Clin Oncol Presented: Chicago, Illinois, June 2013.
180.
Green DM, Breslow NE, D’Angio GJ, Malogolowkin MH, Ritchey ML, Evans AE, Beckwith JB,
Perlman EJ, Shamberger RC, Peterson SM, Dome JS, Grundy PE, Thomas PRM, Kalapurakal
JA. Intra-operative tumor spill and outcome of patients with stage II, favorable histology Wilms
tumor. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer Presented:
Hong Kong, China, September 2013.
GREEN - 37
Presentations
1.
American Cancer Society National Conference on Urologic Cancer - 1986,
Philadelphia, Pennsylvania, April 10, 1986
The treatment of advanced and recurrent malignant genitourinary tumors in children.
2.
A.C. Camargo Hospital, Sao Paulo, Brazil, October 22 - 23, 1986, XXVII Annual Meeting
Study Center of the Fellows of the A.C. Camargo Hospital
Testicular and para-testicular tumors in children: Current concepts.
Lower urinary tract tumors: Rhabdomyosarcoma of the bladder, prostate and vagina:
Surgical approach: Preservation of organs and function, chemotherapy, radiation therapy
and prognostic factors.
3.
A.C. Camargo Hospital, Sao Paulo, Brazil, October 21 - 23, 1986
Non-Hodgkin's lymphoma: New approaches for B-cell type leukemia and extramedullary
relapse.
Wilms' tumor: controversies and epidemiology
Treatment of refractory solid tumors
4.
Brazilian Society of Pediatric Oncology, Ribeirao Preto, Brazil, October 25, 1986
Wilms' tumor: Controversies and epidemiology
5.
American Cancer Society Traveling Oncology Consultant Program, November 3 - 6, 1986
Intercommunity Medical Center, Covina, California
Long-term complications of treatment for childhood cancer
Loma Linda University Medical Center, Loma Linda, California
Testicular tumors in infants and children
Children's Hospital of Orange County, Orange, California
Treatment of Wilms' tumor
Brookside Hospital, San Pablo, California
Long term complications of treatment for childhood cancer
Community Hospital of the Monterey Peninsula, Monterey, California
Long term complications of treatment for childhood cancer
6.
IV International Meeting on Pediatric Oncology, Instituto Nacional de Pediatria, Mexico City,
Mexico, November 17 - 18, 1988
Wilms' tumor: Advances and results of the National Wilms' tumor studies, including for renal
sarcomas of infancy
Late effects of cancer therapy in the child and the future of pediatric oncology
7.
American Cancer Society Workshop of Children and Cancer, Naples, Florida, September
5 - 6, 1991
Effects of treatment on organ function
8.
Pediatric Grand Rounds, Memorial Sloan-Kettering Cancer Center, New York, New York,
November 7, 1991
Long-term survivors of childhood cancer
9.
Visiting Professor, Mayo Clinic, Rochester, Minnesota, November 21 - 22, 1991
Diagnosis and management of patients with Wilms tumor
Long-term survivors of childhood cancer
10.
The First International Conference on Molecular and Clinical Genetics of Childhood
Renal Tumors; Albuquerque, New Mexico, May 14 - 16, 1992
Hemihypertrophy, aniridia and Beckwith - Wiedemann syndrome in children with Wilms tumor
GREEN - 38
11.
American Cancer Society, Workshop on Adolescents and Young Adults with Cancer; Atlanta,
Georgia, October 2 - 3, 1992
Long term effects; defined major concerns
12.
American Cancer Society Traveling Oncology Consultant Program, February 8 - 12, 1993
Orthopedic Hospital, Los Angeles, California: Survivors of childhood cancer: Marriage, offspring,
second cancers and survival
Daniel Freeman Memorial Hospital, Inglewood, California: Survivors of childhood cancer:
Marriage, offspring, second cancers and survival
Riverside General Hospital and University Medical Center, Riverside, California: Survivors of
childhood cancer: Marriage, offspring, second cancers and survival
Presbyterian Intercommunity Medical Center, Whittier, California: Survivors of childhood cancer:
Marriage, offspring, second cancers and survival
Children's Hospital of Orange County, Orange, California: Survivors of childhood cancer:
Marriage, offspring, second cancers and survival
Loma Linda University Medical Center, Loma Linda, California: Wilms tumor - Diagnosis and
treatment
Martin Luther Hospital, Anaheim, California: Survivors of childhood cancer: Marriage, offspring,
second cancers and survival
Loma Linda University Medical Center, Loma Linda, California: Survivors of childhood cancer:
Marriage, offspring, second cancers and survival
Holy Cross Medical Center, Mission Hills, California: Wilms tumor - Diagnosis and treatment
13.
Thirteenth Annual McLemore Birdsong Conference, University of Virginia Health Sciences
Center: Hot Springs, Virginia, May 14, 1993
Survivors of childhood cancer
14.
American Society of Clinical Oncology, Annual Meeting, Special Interest Session: Orlando,
Florida, May 16, 1993
Physical, psychosocial and vocational consequences of surviving childhood cancer
15.
South American Wilms Tumor Workshop: Sao Paulo, Brazil, August 28 - 29, 1993
National Wilms Tumor Studies (USA)
New drugs active in Wilms tumor
New strategies in advanced disease - NWTS studies
16.
Fourth Robert Steel Foundation for Pediatric Cancer Research Symposium: New York, New
York, October 13 - 15, 1993
Organ damage in survivors of childhood cancer
17.
American Academy of Insurance Medicine, Annual Meeting: Chicago, Illinois, September 26,
1994
Further survival of five year survivors of childhood and adolescent cancer
18.
Dana-Farber Cancer Institute: Boston, Massachusetts, March 15, 1995
Protocol Conference: Future Studies of the National Wilms Tumor Study Group
19.
Children's Hospital of Michigan: Detroit, Michigan, March 30 - 31, 1995
Special Oncology Seminar - Wilms tumor: Experience on NWTS - IV
Melissa Ann Krinsky Memorial Lecture - Late Complications in Survivors of Childhood Cancer
20.
McGill University: Montreal, Quebec, Canada, April 26 - 27, 1995
Visiting Professor in Oncology
Medical Grand Rounds, Children's Hospital of Montreal
The Management of Wilms Tumor
Pediatric Grand Rounds, Hospital Ste. Justine
Long Term Side Effects from Treatment of Cancer in Children
GREEN - 39
Oncology Grand Rounds, Montreal General Hospital
Long Term Side Effects from Treatment of Cancer in Children
Hematology Lecture Club, Hospital Ste. Justine
The Management of Wilms Tumor
21.
University of Arizona College of Medicine: 8th International Conference on the Adjuvant Therapy
of Cancer: Scottsdale, Arizona, March 13 - 16, 1996
Late Effects of Adjuvant Chemotherapy for the Treatment of Cancer in Children and Adolescents
22.
American Cancer Society Traveling Oncology Consultant Program, April 1 - 5, 1996
Century City Hospital, Los Angeles, California: Survivors of Childhood Cancer
Orthopedic Hospital, Los Angeles, California: Survivors of Childhood Cancer
Children's Hospital and Health Center, San Diego, California: Survivors of Childhood Cancer
Long Beach Memorial Hospital, Long Beach, California: Survivors of Childhood Cancer
Verdugo Hills Hospital, Glendale, California: Survivors of Childhood Cancer
Loma Linda University Medical Center, Loma Linda, California: Survivors of Childhood Cancer
Kaiser Permanente, Los Angeles, California: Wilms Tumor
Loma Linda University Medical Center, Loma Linda, California: Wilms Tumor
23.
Pediatric Branch, National Cancer Institute: Bethesda, Maryland, June 6, 1996
Core Curriculum Series in Pediatric Hematology-Oncology
Wilms Tumor
24.
American College of Surgeons - 1996 Clinical Congress
Postgraduate Course - Pediatric Neoplasms
San Francisco, California, October 9, 1996
Lessons from NWTS - 3 and NWTS - 4 and Goals of NWTS - 5
25.
9th Asian Congress of Pediatrics: Hong Kong, March 26, 1997
Long-term Complications of Bone Marrow Transplantation
26.
Lady Pao's Children's Cancer Center: Prince of Wales Hospital: Hong Kong, April 1 - 3, 1997
Treatment of Wilms Tumor
Adult Survivors of Childhood Cancer
27.
Kansas City Hematology/Oncology Roundtable: Kansas City, Missouri, April 23, 1997
Adult Survivors of Childhood Cancer
28.
The Children's Mercy Hospital: Kansas City, Missouri, April 24, 1997
Second Annual Ludwina Knapp Memorial Lecture
Adult Survivors of Childhood Cancer
29.
University Hospital of Trondheim: Trondheim, Norway, June 12, 1997
Norwegian Paediatric Society
Survivors of Childhood Cancer
30.
First International Meeting of Pediatric Oncology: Caracas, Venezuela, November 20 - 22, 1997
Late Effects of Therapy
Management of Wilms Tumor
Chemotherapy for Germ Cell Tumors
31.
Mount Sinai Hospital: New York, New York, April 9, 1998
Jason Bennette Memorial Lecture
Wilms Tumor: A Paradigm for Clinical Trials
32.
Memorial Sloan-Kettering Cancer Center: New York, New York, December 10, 1998
Progress in the Management of Wilms Tumor
GREEN - 40
33.
Japan Society of Clinical Oncology: Gifu, Japan, October 13, 1999
Progress in the Management of Wilms Tumor
34.
Japan Wilms Tumor Study Group: Tokyo, Japan, October 15, 1999
Wilms Tumor and Late Effects of Therapy
35.
Saint Louis University School of Medicine, Pediatric Grand Rounds: Saint Louis, Missouri,
November 17, 1999
Long Term Survivors of Childhood Cancer
36.
Saint Louis University School of Medicine; Pediatric Tumor Board: Saint Louis, Missouri,
November 18, 1999
Management of Wilms Tumor
37.
International Congress on Pediatric Hematology/Oncology; Shanghai Children’s Medical Center
Shanghai, China, October 18 – 20, 2000
Diagnosis and Management of Wilms Tumor
38.
American Society of Clinical Oncology: San Francisco, California, May 12 and 14, 2001
Meet the Professor
Diagnosis and Management of Wilms Tumor
39.
China Welfare Institute: Children’s Palace, Shanghai, China
March 16 – 17, 2002
Wilms Tumor
40.
2 SIOP Asia Meeting, Ashok Hotel, Delhi, India: November 22 – 24, 2002
Survivors of Childhood Cancer
41.
Columbia University: New York, New York ; September 15, 2003
Wilms Tumor
42.
3 rd SIOP Asia Meeting: Dhaka Sheraton Hotel, Dhaka, Bangladesh; February 27, 2004
Survivors of Childhood Cancer
43.
6 Giulio D’Angio Lectureship: Abramson Cancer Center at the University of Pennsylvania
Philadelphia, Pennsylvania; March 31, 2004
Diagnosis and Treatment of Wilms Tumor
44.
Marshfield Clinic: Marshfield, Wisconsin; August 20, 2004
Survivors of Childhood Cancer
45.
National Kidney Foundation: Columbia University Medical Center: New York, New York, April 29,
2005
Progress in the Treatment of Wilms’ Tumor
46.
Australia New Zealand Children’s Hematology and Oncology Group Annual Meeting: Melbourne,
Australia; June 10 – 12, 2005
Adolescent and Adult Survivors of Pediatric Cancer
Advancement in Treatment of Wilms Tumor
Pediatric Cancer Research – Regulatory Issues
47.
4th SIOP Asia Meeting: Everbright Hotel and Convention Center, Shanghai, China; April 6, 2006
Progress in the Management of Wilms Tumor
nd
th
GREEN - 41
48.
Hospital Oncology Parent Education (H.O.P.E.) Day 2006: Rydges Parramatta Sydney, Rosehill,
Australia; July 30, 2006
Long-term Follow-up of Childhood Cancer Treatment
49.
Children’s Hospital at Westmead: Westmead, Australia; August 1 – 2, 2006
Recent Advances in Management of Wilms Tumor
Pregnancy Outcome After Childhood Cancer
50.
European Symposium on Late Complications After Childhood Cancer: Lund University;
Sweden; April 19 – 20, 2007
Late Effects of Childhood Cancer
51.
Department of Epidemiology and Cancer Control: Saint Jude Children’s Research Hospital,
Memphis, Tennessee; April 23, 2007
Fecundity and Fertility of CCSS Participants
52.
Texas Children’s Cancer Center Research Conference: Texas Children’s Hospital, Houston,
Texas; April 26, 2007
Advances in the Diagnosis and Treatment of Wilms Tumor
53.
Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio; May 21, 2010
Fertility and Reproductive Outcomes After Treatment For Childhood Cancer
54.
Advocate Hope Children’s Hospital, Chicago, Illinois; November 3, 2010
Long-term Survivors of Childhood Cancer – Outcomes and Medical Care
55.
Children’s Hospital of Los Angeles/Pablove Foundation, Los Angeles, California; November 13,
2010
Chronic medical conditions, health status, and health care practices of survivors of Wilms tumor
56.
Malaysian Society of Pediatric Hematology and Oncology, Kuala Lumpur, Malaysia; September
24 - 25, 2011
Challenges in Childhood Cancer Survivorship
Fertility Issues in Childhood Cancer Survivors
57.
10 International Kidney Cancer Symposium, Chicago, Illinois; October 14, 2011
Pediatric Renal Tumors
Long-term Follow-up and Outcome
58.
American Pediatric Surgical Association, San Antonio, Texas; May 21, 2012
Robert E. Gross Memorial Lecture
The Evolution of Treatment for Wilms Tumor
59.
Visiting Professor, Division of Hematology/Oncology, Children’s Mercy Hospital, Kansas City,
Missouri; September 25, 2012
The Evolution of Treatment for Wilms Tumor
60.
Divisional rounds, Division of Haematology/Oncology, Hospital for Sick Children, Toronto,
Ontario, Canada; September 27, 2012
The Evolution of Treatment for Wilms Tumor
61.
Scientific Meeting, Section on Urology, American Academy of Pediatrics, New Orleans,
Louisiana, October 21, 2012
Long-Term Follow-Up of Survivors of Pediatric and Adolescent Testis Tumors in 2012
Lund,
th
GREEN - 42
HOSPITAL ACTIVITIES
Roswell Park Cancer Institute
Pharmacy-Pharmacology Committee
04/1979-01/1992
Clinical Investigation Committee
01/1980-12/1984
Transfusion Committee
Chairman
05/1981-06/1992
07/1987-06/1992
Cancer Committee
12/1983-12/1984
Medical-Legal Committee
12/1986-12/1987
Library Acquisition Committee
01/1987-01/2008
Biomedical Research Grant Committee
12/1987-05/1991
Executive Committee of the Medical Staff
At-Large Representative
Vice President
04/1988-04/1989
04/1989-04/1990
Human Genetics Core Grant Steering Committee
04/1995-01/2008
Appointment and Promotions Committee of the
Clinical Staff
04/1995-04/1997
Bylaws Committee
12/1996-12/1997
Task Force on Managed Care & Marketing
04/1997-04/1998
Scientific Review Committee
05/1997-05/2000
Conflict of Interest Committee
12/2003-01/2008
Ethics Committee
08/2004–01/2008
Sunrise Project Physician Workgroup Committee
06/2005–01/2008
Finance, Access and Compliance Committee
06/2005–01/2008
Laboratory Information Management System Committee 07/2005–01/2008
Children's Hospital
Cancer Committee
01/1987-01/2008
Medical Records Committee
01/1987-09/1992
St. Jude Children’s Research Hospital
Institutional Review Board
Vice-chairman
Chairman
8/2008 - Present
8/2010 - 9/2013
9/2013 - Present
GREEN - 43
Clinical Protocol Scientific Review and
Monitoring Committee
8/2009 – 7/2011
Data Safety Monitoring Board
7/2011 - Present
NATIONAL INSTITUTE OF HEALTH
Site Visitor
02/87
MD Anderson Hospital & Tumor Institute
Pediatric Intergroup Statistical Office
Site Visitor
06/87
St. Jude Children's Research Hospital
Solid Tumor Program Project
Review Panel
11/98
Chemoprevention in Genetically-Identified High-Risk Groups:
Interactive Research and Development Projects
Review Panel
09/03
Long-Term Cancer Survivors: Research Initiatives
Review Panel
04/02
Loan Repayment Program for Pediatric Research
Review Panel
04/03
Loan Repayment Program for Pediatric Research
Review Panel
04/04
Loan Repayment Program for Pediatric Research
Review Panel
04/05
Loan Repayment Program for Pediatric Research
Review Panel
04/06
Loan Repayment Program for Pediatric Research
Review Panel
04/07
Loan Repayment Program for Pediatric Research
Reviewer
09/04
Clinical and Integrative Cardiovascular Sciences Study Section
Reviewer
12/04
Clinical and Integrative Cardiovascular Sciences Study Section
Review Panel
03/10
Endocrinology, Metabolism, Nutrition and Reproductive Sciences
Integrated Review Group (EMNR IRG)
PDQ Statement on Wilms' Tumor, 1990
Member
10/10-present Pediatric and Adolescent Solid Tumor Steering Committee
National Cancer Institute
DEPARTMENT OF DEFENSE
Panel Member 09/96
US Army Medical Research and Material Command
GREEN - 44
Breast Cancer Research Program Peer Review Panel - Behavioral and Social Sciences 2
Panel Member 09/97
US Army Medical Research and Material Command
Breast Cancer Research Program Peer Review Panel - Behavioral and Social Sciences 2
Panel Member 09/98
US Army Medical Research and Material Command
Breast Cancer Research Program Peer Review Panel - Behavioral and Social Sciences 2
AMERICAN CANCER SOCIETY
Scientific Advisory Committee on Clinical and Cancer Control Investigations
II - Psychosocial and Behavioral Research
Ad hoc Member 1993
Member
1994-1997
DUTCH CANCER SOCIETY
Grant reviewer 07/00
Grant reviewer 07/03
Grant reviewer 05/12
CANCER UK
Site Visit
10/02
Grant reviewer 04/06
University of Manchester/Manchester Children’s Hospital (Jillian
Birch, Ph.D. - Principal Investigator)
University of Sheffield – Christine Eiser, Ph. D – Principal investigator
NATIONAL CANCER INSTITUTE OF CANADA
Grant reviewer 10/03
British Columbia Cancer Cancer Agency (Mary McBride, M.Sc –
Principal Investigator)
Grant reviewer 10/04
British Columbia Cancer Cancer Agency (Mary McBride, M.Sc –
Principal Investigator)
BRITISH COLUMBIA CANCER AGENCY
01/06 – Present External Advisory Board – Childhood/Adolescent/Young Adult Survivors
Research Program (Mary McBride – Principal Investigator)
CANADIAN INSTITUTE FOR HEALTH RESEARCH
2/2010
8/2010
Late Effects of Pediatric Cancer RFA Development Workshop
Late Effects of Pediatric Cancer – Review Panel Chair
UNIVERSITY OF TORONTO
9/2012
External Reviewer – M. Sc. Thesis defense – Amy Lee Chong,
STICHTING KINDEREN KANKERVRIJ (FOUNDATION CHILDREN CANCERFREE)
GREEN - 45
4/2013
PEDIATRIC ONCOLOGY GROUP
Member
Member
Member
Member
Member
Member
Member
Chairman
Chairman
Chairman
Member
Member
1991-2001
1985-2001
1985-1993
1985-2001
1988-1992
1991-1992
1991-1992
1988-1992
1985-1993
1993-2001
1988-1994
1995-2001
Executive Committee
Neuroblastoma and Other Embryonal Tumors Core Committee
Bone and Soft Tissue Sarcoma Core Committee
Ewing Sarcoma Core Committee
Hematology Discipline Core Committee
Supportive Care Core Committee
Cancer Control Core committee
Late Effects Committee
Wilms Tumor Subcommittee
Wilms Tumor Committee
Protocol Review Committee
Data and Safety Monitoring Committee
Co-Coordinator
Co-Coordinator
Coordinator
Co-Coordinator
Coordinator
Co-Coordinator
Co-Coordinator
8653/4
8000
8650
8158
8692
8850
8890
Coordinator
9440
Non-Rhabdomyosarcoma Soft Tissue Sarcomas
National Wilms' Tumor Study - III
National Wilms' Tumor Study - IV
Wilms' Tumor Long Term Follow-up Study
Continuous Infusion 5-Fluorouracil in Pediatric Solid Tumors
Treatment of Ewing's Sarcoma
Limited Institution Pilot Study of Cisplatin, Etoposide, and
Ifosfamide in Children with Advanced Malignant Disease
National Wilms Tumor Study - 5:Therapeutic and Biology
Protocol
National Wilms Tumor Study - 5:Long-Term Follow-Up Study
National Wilms Tumor Study - 5:Treatment of Relapsed Patients
Intensive Treatment and Bone Marrow Transplantation for
Patients with Relapsed Wilms Tumor
Coordinator
9442
Coordinator
9444
Co-Coordinator 9445
Site Visitor
Site Visitor
Site Visitor
Site Visitor
08/88
08/94
01/95
01/96
Site Visitor
01/97
Institutional Audit; University of Miami
Institutional Review; Hospital of the University of Sherbrooke
Institutional Review; Walt Disney Memorial Cancer Institute
Institutional Review; Medical City Dallas Hospital/Texas
Oncology, P.A.
Internal Site Visit; Statistical Office, Gainesville, Florida
CHILDRENS ONCOLOGY GROUP
Member
Chairman
Member
Member
Member
Chairman
2000
1999 - 2001
2000 - 2008
2001 - 2006
2006 - 2013
2007
Interim Executive Committee
Wilms Tumor Committee
Epidemiology Steering Committee
Solid Tumor Data and Safety Monitoring Committee
Data and Safety Monitoring Committee
ST. JUDE CHILDREN’S RESEARCH HOSPITAL
Cancer Prevention and Control Program
External Advisory Board Member
1998-2000
Division of Behavioral Medicine
Scientific Advisory Board Review Member
2002
GREEN - 46
UNIVERSITY OF MINNESOTA, CHILDREN’S CANCER RESEARCH FUND
Grant Reviewer 05/02
Grant Reviewer 05/03
Grant Reviewer 04/04
Grant Reviewer 04/05
Grant Reviewer 04/06
Grant Reviewer 06/07
COMMUNITY ACTIVITIES
Association for the Research of Childhood Cancer
Medical/Scientific Advisory Board
Chairman
Board of Management
Massachusetts Institute of Technology
Educational Council
1987-2007
1996
1990-1991
1982-Present
American Cancer Society, New York State Division
Service and Rehabilitation Committee
1988-1995
Greater Buffalo Convention and Visitors Bureau
Buffalo Ambassador
1989-2007
Camp Good Days and Special Times
Buffalo Advisory Board
1990-1995
TEACHING ACTIVITIES
School of Medicine and Biomedical Sciences, University at Buffalo, State University of
New York
PEDIATRIC 700 C
Pediatric Clinical Clerkship
PEDIATRIC 814 C
Pediatric Hematology Oncology
IDM 500
First Year Selection Program
Section A. Human and Biological Issues in Cancer
IDM 600-0
Introduction to Clinical Medicine
PMY 601-0
Fundamentals of Pharmacology
Mini Medical School
UNIVERSITY ACTIVITIES
Western New York Health Sciences Consortium
Cancer Task Force
1987
Robert Wood Johnson Foundation Planning Grant
Steering Committee
Primary Care Research Subcommittee
1993
GREEN - 47
Faculty Council
Representative, Department of Pediatrics
1989-1991
Committee on Appointment and Promotion
to Clinical Rank
1990
Appointments, Promotions, Tenure and
Privileges Committee
Chairman
1990-1995
1990-1992
Affiliated Institutions, Clinical Affairs and
Graduate Medical Education Committee
1992-1995
Steering Committee
Ad Hoc Committee for the Examination of SUNY
2000 Document as Related to the Health Sciences
Chairman
1992
1993
Department of Pediatrics
Committee on Appointments and Promotions
1991-2007
Vice-Chairman for Academic Affairs
1997-2000
EDITORIAL ACTIVITIES
Editorial Board
American Journal of Clinical Oncology
European Journal of Cancer - Pediatric Advisory Panel
The Oncologist
Medical and Pediatric Oncology
Journal of Clinical Oncology
Pediatric Blood and Cancer
Ad Hoc Reviewer
American Journal of Pediatric Hematology Oncology
Cancer Treatment Reports
Journal of Clinical Oncology
Cancer
Pediatrics
New England Journal of Medicine
Clinical Pediatrics
Blood
American Journal of Pathology
Journal of Pediatrics
European Journal of Pediatrics
Cancer Research
Pediatric Blood and Cancer
Journal of Pediatric Hematology and Oncology
01/30/2014
1989-2000
1995-2012
1995-2000
1998-2004
2000-2003
2004-Present